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Pharmaceutical companies accrued fines of over $30 billion within 25 years because of 
noncompliance with regulations. Noncompliance with regulations results in fines and an 
adverse impact on company profitability. Some pharmaceutical company managers lack 
effective strategies to ensure overall company compliance with regulation. Based on 
complexity leadership theory, the purpose of this single case study was to explore 
strategies pharmaceutical company managers used to ensure compliance with regulatory 
requirements in Nigeria. The target population was functional managers purposely 
selected because they had successfully implemented strategies for compliance with the 
regulatory requirements in Nigeria. Data were collected through face-to-face and 
telephone interviews with 4 company managers and from company records, regulatory 
documents, and websites. Analysis of data involved using computer-assisted qualitative 
data analysis tools and content analysis to code and identify patterns and themes. 
Findings revealed 3 prominent themes: establishment of regulatory affairs unit and 
engaged leadership; hiring of qualified of employees, training, and continuous learning; 
and strategies to navigate through barriers to enhance regulatory compliance. The 
implications for positive social change lie in the availability of affordable pharmaceutical 
products with implications for the overall health of communities. Compliance with 
regulatory requirements helps to ensure that pharmaceutical companies develop high 
quality and safe products, which are critical in healthcare leading to the prevention and 
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Section 1: Foundation of the Study  
Compliance with regulations is critical to business performance and assurance of 
safety and product performance in the pharmaceutical industry (Ding, Eliashberg, & 
Stremersch, 2014; Proches & Bodhanya, 2015). In recent years, regulatory 
noncompliance in the pharmaceutical industry is on the rise and is becoming a challenge 
to company leaders and managers (Page, Cyr, & Richardson, 2015). Wang, Zheng, Ren, 
and Sun (2016) found that the U.S. Food and Drug Administration issued 997 warning 
letters to medical products manufacturers in specific areas of the manufacturing process 
during 2007 to 2014. The regulatory requirements for pharmaceutical products are always 
evolving, a condition that presents an ongoing challenge to managers in pharmaceutical 
organizations (Thach, 2015). Noncompliance with regulations results in huge fines and a 
significant amount of settlement with a considerable impact on company image and 
profitability (Mulinari, 2016). Having a strategy in place to ensure personnel compliance 
with regulation is critical to the avoidance of the adverse impact of noncompliance in the 
sector (Sabel, Herrigel, & Kristensen, 2017).   
Background of the Problem 
The increasing number of litigations and violation citations in the pharmaceutical 
industry are indications of widespread problems with business operations in the sector 
(Rodwin, 2015). As regulation becomes precise, encompassing, and complex, reports of 
increasing incidence of noncompliance is on the rise because of rising costs and lack of 
knowledge of regulations (Lemmens & Gibson, 2014). Nielsen and Parker (2012) noted 
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that despite the importance of compliance with regulations, not much is known about 
companies’ compliance with regulations.  
Complying with regulations requires personnel knowledge and understanding of 
regulations to avoid violation or noncompliance (Mendoza, Dekker, & Wielhouwer, 
2016). Nielsen and Parker (2012) rationalized that motivation is vital in the consideration 
of the topic of regulatory compliance in companies. As such, company personnel have 
different motivations to ensure compliance with regulations, meaning that the attitude of 
personnel to compliance is dependent on several factors including customers, capital, 
skills, technologies, trade associations, and communities (Lynch-Wood & Williamson, 
2014).  
The increase in noncompliance and the resulting impact on pharmaceutical 
companies resulted in the need for an effective strategy to ensure managers and 
subordinates take steps that lead to overall compliance as they perform critical roles in 
the product lifecycle (Arora, Christman, Mays, & Schmidt, 2013). Herzberg (2015) 
posited that several factors are involved in personnel motivation, and a greater 
understanding and application of those factors results in the desired outcome. Further 
research on regulatory compliance strategies in pharmaceutical companies is necessary to 
provide pharmaceutical managers strategies that other managers in pharmaceutical 
companies used to ensure compliance with regulatory requirements.  
Problem Statement 
Noncompliance with government regulations in the pharmaceutical industry is on 
the rise and impacts pharmaceutical companys’ profitability (Page et al., 2015). The US 
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FDA reported a 64% increase in the number of current Good Manufacturing Practice 
(cGMP) noncompliance from 2007 to in 2012 (Wang, Zheng, Ren, & Sun, 2016). 
Almashat, Wolfe, and Carome (2016) found that pharmaceutical companies paid over 
$30 billion over 25 years for various violations in the United States with the resultant 
impact on company profit.  The general business problem is that noncompliance with 
regulation has a negative impact on company revenue, brand value, product development, 
product approval, and a number of regulatory investigations. The specific business 
problem is that some pharmaceutical company managers lack strategies to ensure 
compliance with regulatory requirements.  
Purpose Statement 
The purpose of this qualitative single case study was to explore strategies that 
managers in pharmaceutical companies use to ensure compliance with regulatory 
requirements. The target population for this study consisted of 4 pharmaceutical 
managers in a Nigerian pharmaceutical company who successfully implemented 
strategies for compliance with the regulatory requirements in Nigeria. The implications 
for social change include the potential to improve the abilities of managers to ensure 
compliance in a regulated environment, which might lead to increased access, 
availability, and affordability of pharmaceutical products by individuals with limited 
access to good healthcare. 
Nature of the Study 
I used the qualitative research method in this study. A qualitative method allows a 
researcher to study a phenomenon in depth using open-ended questions that enable 
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researchers to discover new, rich, and nuanced phenomena based on participants’ 
experiences (De Massis & Kotlar, 2014; Yin, 2014). Researchers in qualitative research 
focus on perceptions and experiences taken from only a few representative participants; 
hence, researchers cannot generalize the outcome of a study to a population (Starman, 
2013). I used the qualitative method to explore and understand the strategies used by the 
research participants to ensure compliance with regulatory requirements.  
The quantitative method is not suitable for studying participants’ experiences or 
nuanced phenomena; rather, it involves data collection through sampling or experiments 
to test hypothesis, analyze data using statistical or mathematical forms, and the results are 
generalizable (Bernard, 2013; Brockington, 2014). Mixed methods, a combination of 
both quantitative and qualitative research (Dumbili, 2014), was not suitable for this study 
because I did not test or build theories.  
 I selected a qualitative single case study design for this study. Scholars use case 
study to gather in-depth information and enable review and examination of a bounded 
system involving a real-life phenomenon (Morse & McEnvoy, 2014; Yin, 2014). A case 
study methodology was most appropriate for this study. Case study is a strategy available 
to researchers for studying topics with relatively few previous studies (Yin, 2014). In 
addition, researchers use ethnographic or phenomenological design in qualitative 
business research (Yin, 2014). In an ethnographic study, the researcher studies beliefs, 
the way of life, and culture of a group of people through observation or participation 
(Ferguson, 2016). Ethnographic approach was not suitable for this study because my 
focus was not on the culture of the people. In phenomenology, the researcher examines 
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lived experiences of individuals to understand the root meaning of a phenomenon (Gill, 
2014). I did not select phenomenology for this study because I did not seek to explore 
lived experiences of those experiencing a phenomenon. I concluded that case study 
approach would be appropriate for this study because I explored the strategies used by 
managers in a single pharmaceutical company to ensure compliance with regulatory 
requirements. 
Research Question 
The research question for this study was the following: What strategies do 
pharmaceutical company managers use to ensure compliance with regulatory 
requirements. 
Interview Questions 
1. What is your role in ensuring compliance with government regulations in 
your company? 
2. What strategies do you use to prevent noncompliance with government 
regulations? 
3. How do you communicate regulatory requirements within your company? 
4. What specific strategies do you use to ensure regulatory compliance? 
5. What challenges do you encounter in implementing strategies for compliance 
with regulatory requirements?  
6. How do you address the challenges to the implementation of strategies for 
noncompliance with government regulations? 
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7. How do you assess the effectiveness of your strategies to prevent 
noncompliance? 
8. What other relevant information about compliance with regulatory 
requirements can you provide? 
Conceptual Framework 
The theory that I used as the conceptual framework of this study was the 
complexity leadership theory. Marion and Uhl-Bien developed the complexity leadership 
paradigm in 2001 (Marion & Uhl-Bien, 2001). Uhl-Bien, Marion, and McKelvey (2007) 
extended the works on complexity leadership by addressing complex interactive 
dynamics from which adaptive outcomes emerge. Uhl-Bien et al. used the complexity 
leadership theory to explain a leadership paradigm based on enabling the learning, 
creative, and adaptive capacity of complex adaptive systems. The key constructs of 
complexity leadership theory are: (a) administrative leadership based on strict control and 
bureaucratic hierarchy; (b) adaptive leadership based on creative problem solving, 
generating new conditions and learning; and (c) action-centered leadership that involves 
immediate decision-making mechanisms used in crises and dynamic productivity.  
The complexity leadership theory provides a lens through which I explored 
effective strategies that managers use to ensure compliance as they pertain to an 
increasingly dynamic of instability emanating from regulatory requirements. The 
complexity leadership theory is an appropriate framework for this study. Hazy and Uhl-
Bien (2015) noted that complexity leadership-inspired research resulted in new insights 
into the mechanisms for studying leadership in a dynamic environment by focusing 
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leadership efforts on behaviors that help improve organizational performance. According 
to Murray (2017), leadership involving interactive model facilitates collaboration across 
networks and the performance of a task. Baltaci and Balci (2017) highlighted how 
administrators respond to environmental dynamics and relationships necessary for 
organizational survival from the perspective of complexity leadership theory. 
Operational Definitions 
Complex system: A complex system consists of many entities that display a high 
level of interactivity (Cordon, 2013). 
Compliance: Compliance is an array of behavioral and attitudinal responses of 
individuals or corporations to regulations (Mendoza et al., 2016). 
Interaction: Interaction is a dynamic mechanism of interdependent behaviors and 
relationships leading to the emergence of unrecognizable subsets when perceived as a 
linear combination of the initial agents (Proches & Bodhanya, 2015). 
Regulations: Regulations are a variety of government rules or authorities that 
affect individuals and organizations (Baldwin, Cave, & Lodge, 2012), which 
governments institute to strike a balance between the benefits and risks of new products 
(Sorenson & Drummond, 2014). 
Assumptions, Limitations, and Delimitations 
Assumptions 
Assumptions in research are statements that researchers hold as factual but are 
unproven (Marshall & Rossman, 2016). My first assumption was that each participant 
would provide accurate and truthful information. My second assumption was that 
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participants would provide accurate descriptions of the strategies used by the company to 
ensure compliance with regulatory requirements. My final assumption was that the data 
and documents obtained from the organization would be current and help answer the 
research question. 
Limitations 
Limitations refer to potential weaknesses of a study that are out of researcher’s 
control (Ritchie, Lewis, Nicholls, & Ormston, 2014). The first limitation of this study 
was that I explored only one pharmaceutical organization. The second limitation was the 
inability to generalize the findings, given that the study was qualitative. The third 
limitation was restricted access to some data due to the need to protect company 
intellectual property and maintain confidentiality, which limited the available information 
to the researcher. A researcher driving the course of a discussion may influence the 
response of participants. 
Delimitations 
Delimitations are distinctive features resulting from restrictions or boundaries in 
the scope of a study and the concerted efforts of the researcher to narrow the scope during 
the development of the study plan (Childers, 2014; Marsall & Rossman, 2014). An 
important delimitation in this study was the use of purposive sampling to select research 
participants. The choice of Nigeria as the geographical location of this study was a 
delimitation as well. Another delimitation was the intentional restriction of participants in 
the organization to those who were directly involved in management functions and 
exercising supervisory role. 
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Significance of the Study 
The study findings may be of value to businesses because of the understanding it 
may offer fundamental strategies that result in regulatory compliance. Given that the 
pharmaceutical industry is among the highly regulated industries, managers and 
employees in the regulated industry may use the findings to reduce or eliminate the 
incidence of noncompliance with regulations. As other scholars have noted, using 
efficient strategies results in safer pharmaceutical products and potential for higher 
profitability (Page et al., 2015).  
Contribution to Business Practice 
The associated costs of compliance with government regulations constitute a 
critical burden in the pharmaceutical industry, and compliance with government 
regulations is critical to the business success of pharmaceutical companies ((Eger & 
Mahlich, 2014; Liberti et al., 2016). Responding to regulatory requirements is of 
paramount importance to the success of many business organizations (Rollings, 2017). 
Researchers show that noncompliance with regulatory requirements impacts companies’ 
turnover (Nielsen & Parker, 2012). Pharmaceutical company managers may use the 
results of this study to develop new strategies required to ensure compliance with 
regulations, leading to the emergence of the desired outcome and economic activities. 
The findings from this study may provide insights on strategies that may help functional 
managers minimize regulatory noncompliance and increase profitability. Functional 
managers may gain insights on strategies to minimize regulatory noncompliance and 
increase profitability based on the findings of this study. 
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Implications for Social Change 
Social change results from interdependencies between businesses and the 
environment as they interact at various levels (Harper & Leicht, 2015). Social change is 
more prominent in successful companies creating socially desirable outcomes such as 
generating consumer goods that can contribute to the development of human welfare, as 
with the availability of new medications and filling gaps in social provision (Konda, 
Starc, & Rodica, 2015; Ney, Beckmann, Gräbnitz, & Mirkovic, 2014). Developing a 
strategy to for compliance with regulations enables pharmaceutical organizations to play 
key roles in ensuring cost reduction of pharmaceutical products. Reduction in costs 
emanates from compliances reducing associated costs with noncompliance. Muzaka 
(2013) viewed the availability of pharmaceuticals as a social function that represents 
bargaining among government, business, and society. Strategies to improve adaptation to 
regulatory changes may lead to the affordability of pharmaceutical products in most 
markets, particularly in developing countries given that strategies are crucial to the 
supply and availability of pharmaceuticals to the population (Niessen & Khan, 2016). 
A Review of the Professional and Academic Literature 
The purpose of this study was to explore strategies that managers in 
pharmaceutical companies use to ensure compliance with government regulations. In this 
literature review, I provide a comprehensive, critical analysis and synthesis of complexity 
leadership, rival theories, and a general review of the pharmaceutical regulation. The 
literature review consists of three key themes: (a) complexity leadership theory paradigm, 
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(b) supporting and rival theories, and (c) the role of regulation in the pharmaceutical 
industry.  
The literature came from multiple databases, journals, and search engines. In 
seeking sources, I used keywords such as complexity theory, compliance, congruency, 
Nadler and Tushman, regulation, organizational learning, organization ambidexterity, 
pharmaceutical regulation, and drug approval. The search strategy included using 
Boolean operator keywords to search databases including Google Scholar, Science 
Direct, ProQuest Central, EBSCOhost, ABI/Inform Complete, Emerald Management, 
SAGE Premier, and PubMed. I identified additional peer-reviewed publications by 
reviewing the bibliographies of articles retrieved from databases. The literature search 
resulted in 233 articles, of which 221 articles (95%) were peer reviewed. Of the peer-
reviewed articles, 187 (85%) had publication dates within 5 years of my anticipated 
graduation year of 2018. 
Complexity Leadership Theory 
Complexity leadership theory (CLT) is an innovative approach to perceiving and 
managing complex organizational behavior (Baltaci & Balci, 2017), particularly in an era 
of a knowledge economy (Uhl-Bien et al., 2007). Marion and Uhl-Bien (2001) introduced 
complexity leadership as an application of complexity theory to the study of 
organizational behavior and the practice of leadership. Complexity leadership theory, 
according to researchers, is an emerging theory viewed from different angles including 
social systems. Research into the theory continued to expand to understand how micro 
processes affect follower and leader outcomes (Dinh et al., 2014). Researchers using 
12 
 
several approaches have conceptualized organizational complexity in relation to size and 
technology, design structure, and interdependence among agents within and outside an 
organization (Walton, 2014). The interactions of the components in an organization result 
in emergent properties and these interactions are nonlinear such that a change in one 
component may lead to a large or negligible impact on the whole organization (Gerrits & 
Verweij, 2015). While changes in laws and regulations of a project may appear to be the 
same for all organizations in a particular industry, the result in each organization might 
be different. As such, it is difficult to predict the type of adaptations required by each 
organization based on external changes or turbulence experienced by organizations 
(Melton, 2017). Complexity leadership scholars view leadership as emanating from 
collaboration, complex systems thinking, and innovation mindset to improve cost and 
quality (Weberg, 2012). 
Complex leadership theory is a framework that scholars use to account for the 
development of creative and adaptive strategies and behaviors. The strategies permit 
control structures suitable for coordinating organizations and generating results 
appropriate to the vision and mission of the system (Uhl-Bien et al., 2007). Scholars of 
CLT distinguish between technical and adaptive leadership challenges encountered in an 
organization. The resolution of a technical challenge is through the application of specific 
technical skill but the solution to adaptive challenges is through emergence based on 
interactions of individuals in the organization (Bailey et al., 2012). Uhl-Bien et al. 
described the three elements of complex leadership, while Hazy and Uhl-Bien (2015) 
further enhanced the complex leadership functions based on Uhl-Bien et al. proposition. 
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Uhl-Bien et al. grouped leadership into (a) administrative, (b) adaptive, and (c) enabling 
leadership. Proponents of complexity leadership theory explained in broad terms the three 
broad types of leadership: (a) administrative leadership, predicated on traditional, 
bureaucratic views; (b) leadership that structures and enables conditions; and (c) adaptive 
leadership. Hazy and Uhl-Bien (2015) explored complexity study and clarified leadership 
influence in the enabling of organizations to perform and adapt. Confronting an 
increasing level of uncertainty in business environments, organization leaders have felt 
compelled to adapt by mirroring external conditions within the internal environment 
(Fitzgerald, Ferlie, McGivern, & Buchanan, 2013; Tong & Arvey, 2015). Uhl-Bien et al. 
(2007) itemized four critical assumptions of complexity leadership theory: (a) the 
informal dynamic entrenched in context-the nature of interactions and interdependencies 
among agents, hierarchical divisions, organizations, and environments; (b) leadership as 
an emergent, interactive force leading to adaptive outcomes; (c) adaptive leadership that 
occurs in emergent, informal adaptive dynamics in organizations; and (d) adaptive 
leadership that requires exploration, new discoveries, and adjustments. 
Hazy and Uhl-Bien (2015) surmised that leadership is not confined to an 
individual but a form of social and relational organizing among different independent 
individuals forming a system of activity. Given the massive regulations imposed on 
pharmaceutical companies amid globalization and technological developments, 
organizational leaders face complex competitive landscapes driven by regulatory changes 
(Duggal, Kashyap, & Kakar, 2014; Palumbo et al., 2015). Organization leaders’ 
traditional approach to leadership often relied on leaders exercising control to determine 
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and direct the future, whereas complex systems leaders facilitate behaviors that enable 
organizational effectiveness rather than control (Marion, Christiansen, Klar, Schreiber, & 
Erdener, 2016). The theoretical framework of this study has several implications for 
leaders in the pharmaceutical industry, as it may create an alternative approach for 
leaders to ensure compliance with regulatory requirements. Scholars apply complexity 
leadership theory to the study of knowledge-based organizations where knowledge about 
a product or service is a major source of competitive advantage to generate unique 
contributions to the business (Uhl-Bien et al., 2007). Baltaci and Balci (2017) noted that 
leadership in organizations is a significant mechanism capable of managing the 
turbulence resulting from changes in technology and innovation. 
Other researchers offered a different view of leadership based on a complex 
perspective of organizations (Hazy & Uhl-Bien, 2015; Marion et al., 2016). Murphy, 
Rhodes, Meek, and Denyer (2017) showed that leaders as enablers disrupt existing 
patterns of behavior, promote innovation, and draws conclusion from emerging events. 
Given that leaders operate in many contexts, Uhl-Bien et al. (2007) argued for a shift 
from the control mechanism perspective to advocating for the development of a 
leadership framework in a fast-paced and unstable environment. Baltaci and Balci (2017) 
noted that CLT is an alternative approach to study contemporary organizations to thrive 
in a volatile, unstable, and chaotic environment. The three primary aspects of complexity 
leadership theory based on the identification and exploration of strategies are adaptive 
leadership, administrative leadership, and enabling (action-centered) leadership. The 
three aspects generate behaviors that promote (a) creativity in organizations, (b) learning, 
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and (c) adaptability in organizations when appropriate complex adaptive system 
dynamics thrive within a bureaucratic setting.  
Complexity leadership theory reflects a significant portion of the core concept of 
complexity theory (Marion & Uhl-Bien, 2001). Comprehending complexity leadership 
requires an understanding of the fundamentals of complexity theory (Uhl-Bien et al., 
2007). Complexity leadership researchers view leadership as an identifiable behavior of 
social and relational organizing between independent heterogeneous individuals 
coalescing into a system of action rather than approaching leadership in the context of an 
individual (Hazy & Uhl-Bien, 2015; Uhl-Bien et al., 2007). The applications of 
complexity concepts to management account for the pattern of social interactions 
between independent heterogeneous agents as they aggregate into a system (Hazy & Uhl-
Bien, 2015). The complexity approach to leadership is about the relevance of the 
overarching organizing effects of individual units, agents, or practices and the impact of 
complex systems. Complex adaptive system problems require new learning, innovation, 
and new behavioral patterns that fit into the paradigm of leadership development in 
which groups learn their way out of a problem. Management development, however, is 
the application of established solutions to known problems.  
Using complexity leadership theory, scholars can study how interacting 
components, whose components are diverse, with a capacity to learn to generate desired 
outcomes (Uhl-Bien et al., 2007). Decision-making processes in organizations involve a 
cross-functional management approach that comprises planning, discussions, and 
resolving issues and implementing decisions for success. Each member of an 
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organization brings specialized knowledge about their function to the organization 
leading to high functioning teams. In complex systems, given the dictates of complexity 
leadership theory, the rules controlling the local interactions change as both internal and 
external factors change.  
System thinking provides a professional and scholarly alternative approach to 
solving and analyzing complicated issues in different fields (Clancy, 2015; Tong & 
Arvey, 2015). Walton (2014) provided examples of complex systems across multiple 
organizations or systems that included school, healthcare, and manufacturing facilities. 
Scholars of systems approach view large organizations such as healthcare organizations 
and pharmaceutical entities as complex systems, suggesting that a different strategic 
approach is necessary for studying such organizations (Caffrey, Wolfe, & McKevitt, 
2016). Hazy (2014) found that human interactions are complex systems with the 
leadership performing the functions of organizing a human activity, including unifying 
individuals into organized groups and developing a vision, ethics, and identity for the 
team. Another function emanating from leadership in complex systems involves changing 
rules to spawn ideas and plans of action (Uhl-Bien et al., 2007), allowing for creativity 
and problem-solving to thrive in the organization. Lastly, leaders change rules in complex 
systems to foster the convergence of divergent individual perspectives and activities into 
a viable and expected outcome. Organization leaders must deal with complexities to 
avoid adverse impact on their organization’s success (Hazy & Uhl-Bien, 2015). 
Researchers from different fields argue that organizations’ paradigms need to 
move toward complex systems in which they and their agents can evolve together 
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(Caffrey et al., 2016; Clancy, 2015). Certain elements of complex organizations may 
themselves be complex, while other elements oscillate between multiple complex 
systems (Byrne, 2013). The interaction of components in a complex organization results 
in emergent phenomena not explained by evaluating each component in a complex 
system (Bone, 2016). A complex systems approach to problem-solving enables 
researchers or practitioners to consider wider ramifications consisting of management, 
leadership, interventions, and the implementation context of these elements (Caffrey & 
Munro, 2017). 
Complexity is a critical component of organizations that affects their success 
(Hanisch & Wald, 2014). The literature on complexity thinking is diverse, traversing 
different disciplines including development, political science, management, biological 
science, and physical science. Complexity theory has its roots in physics, mathematics, 
and biology, but it has expanded into organizations to inform strategic management and 
organizational dynamics. Chandler, Rycroft, Malone, Hawkes, and Noyes (2016) 
identified five core concepts of complexity theory: (a) self-organization, (b) interaction, 
(c) emergence, (c) system history, and (d) temporality. Revolving around the construct on 
complexity are the concepts of chaos, symmetry, entropy, modularity, hierarchy, 
nonlinearity, connectivity, equilibrium, synchronization, schemata, self-organization, and 
self-regulation (Walton, 2014). The interaction of components in a complex system such 
as in pharmaceutical organizations results in an emergent pattern that is difficult to 
understand by evaluating individual agents in the organization (Naghshineh et al., 2014).  
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Organizational functions and operations are more complex given the increasing 
diversification and the number of organizational stakeholders (Baumann & Siggelkow, 
2013). Likewise, in heavily regulated environments, many leaders in organizations follow 
a management system in which regulatory activities lead to an unpredictable emergent 
disturbance that makes it difficult for people to adapt to the change (Battiston et al., 
2016). Using complexity theory has several benefits for understanding complex 
organizations operating in highly regulated industries such as healthcare 
(Thompson, Fazio, Kustra, Patric, & Stanley, 2016). Complexity theory is an alternative 
approach to learn how systems adapt to a disturbance such as regulatory changes through 
self-organizing in a way that permits critical system components to endure over a period. 
The core of complexity theory rests on the understanding of resilience, which is the 
degree to which the system can absorb disturbances as it changes (Bone, 2016). Scholars 
use the core concepts of complexity theory as a theoretical framework to evaluate 
strategies in healthcare to explain the resistance to change. 
The components of complex systems exhibit high levels of interactivity mostly at 
the nonlinear level (Poutanen, Siira, & Aula, 2016), with such systems exhibiting fragile 
behavior (Clancy, 2015). Fragile organizations are readily susceptible to external 
disturbances. Under heavily regulated industries, interactivities result in random events 
initiated by an external trigger or disturbance; organization leaders should learn from 
other leaders how to lead fragile systems (Cordon, 2013). Nevertheless, some 
organizational leaders adapt to changing components and environments through self-
organization, learning, and reasoning giving rise to complex adaptive systems 
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(Nooteboom & Termeer, 2013; Uhl-Bien et al. 2007). From the perspective of 
complexity leadership theory, ability to change and adapt over time through the process 
of learning is critical to the success of an organization in a regulated industry (Caffrey et 
al., 2016; Mendes et al., 2016). 
 Scholars, including Bone (2016), employed complexity theory to explain 
emergent behavior in previously unexplained changes occurring in different systems. The 
results of various studies illustrate the presence of emergence where changes are traced 
but difficult to explain by analyzing an individual agent. Looser organizational 
constraints promote emergent behavior, and people in learning organizations are more 
amenable to complexity as they facilitate adaptive changes (Cordon, 2013). Healthcare 
organizations are ideal for the application of complexity theory due partly to the diversity 
of organizations and interactions among agents in organizations (Thompson et al., 2016). 
Within each healthcare organization, with emphasis on pharmaceutical product 
manufacturers, most processes involve interaction between individuals in manufacturing, 
marketing, regulatory, professional, and the organizational systems in care delivery.  
Complexity theory provides scholars of strategy a framework to explore the 
complexities inherent in complex organizations some lessons from the healthcare systems 
(Caffrey et al., 2016). Complexity theory has advantages as a theoretical tool in that it 
pulls together different viewpoints to develop key concepts and articulates them in a 
systematic approach to explain patterns, behaviors, or phenomena in organizational 
change and policy implementation (Byrne, 2013; Caffrey et al., 2016). Thompson et al. 
(2016) suggested that applying complexity theory to complex systems indicated that 
20 
 
agents will act, respond, and adapt to changes and environments based on their individual 
experiences and viewpoint. 
Four elements highlight the interrelatedness of leadership in organizations 
through the lens of complexity leadership: (a) network conditions, (b) shared leadership, 
(c) organizational learning, and (d) leader skills and knowledge (Clark, 2013). The 
implication of Clark and Uhl-Bien et al. (2007) suggestions is that leaders in 
pharmaceutical organizations cannot predict complex adaptive systems by a standard 
linear equation due to of the interactions between multiple agents of the organization. 
Leadership development in complex organizations, including pharmaceutical companies, 
emerges from nonlinear and disorderly interactions among the agents (Mendes et al., 
2016). Thomson et al. (2016) opined that adequate functioning of each inter-dependently 
connected agent or aggregate depends on the productive state of other actors. The 
interactions are strategic because of actions or decisions by one agent influence reactions 
by others, which reflect interdependence (Hazy & Uhl-Bien, 2015). I described the three 
elements of CLT in the following paragraphs: (a) administrative, (b) adaptive, and (c) 
enabling leadership. 
Administrative leadership. The management team in an organization is the 
administrative leaders where interpersonal influence is predominant (Marion & Uhl-Bien, 
2007).  Uhl-Bien et al. (2007) noted that a top-down, bureaucratic leadership models in 
the last century, thought to be effective in the physical production of goods but not 
conducive to a knowledge-based economy. Scholars of the traditional concept view 
leadership as a deliberate influence on others to attain the desired goal (Epitropaki, Kark, 
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Mainemelis, & Lord, 2017). The contemporary command and control structure of 
leadership is ineffective.  
Marion and Uhl-Bien (2013) outlined the key organizational outcomes of 
administrative leadership are: (a) discipline orientation, (b) consistent routines, (c) role 
clarity, (d) clear chain of responsibility, (f) efficiency, and (g) performance. Under this 
leadership approach, the leaders establish specific tasks and deliverables while using 
discretionary control over resources to bolster successful projects. The leader deploys 
resources, e.g., budgets as structural incentives while simultaneously setting challenging 
but attainable goals. Marion and Uhl-Bien noted that such leaders provide understandable 
roles, targeted training, and follow-up on expected activities while providing resources 
and autonomy for the group.  
Adaptive leadership. Adaptive leadership is a set of strategies and behaviors 
used to facilitate the emergence of solutions from the interactions of individuals in the 
organization confronting a challenge (Anderson et al., 2015). The impact of 
environmental change results in internal action within the organization that allows for the 
possibility to grapple with threats and challenges (Blomme, Kodden, & Beasley-Suffolk, 
2015). The changes create the need for managers and other leaders to adapt for the 
organization to survive and the strategies deployed by managers to adapt include 
communication, active participation, and influence techniques (Bloome et al., 2015). As 
managers face external turbulence and complex problems, they require continuous 
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adjustment to make the organizations thrive, but many organization leaders cannot cope 
with the change required. 
One of the core propositions contained in CLT is adaptability, which enhances 
performance and innovation that occurs in regular interactions of individuals acting in 
response their environments (Uhl-Bien et al., 2007). Adaptability is a fundamental 
component of complex leadership theory, helping organization leaders to respond better 
to the demands of the environment and formulate strategies favorable to innovations 
(Nooteboom & Termeer, 2013). However, certain factors, including employees, 
organizational characteristics, and culture, influence decisions within organizations 
(Bourke & Roper, 2014). Bourke & Roper (2014) also found significant and consistent 
evidence that the impact of knowledge formed by experiential learning has potential 
commercial, organizational, and healthcare delivery benefits in a health organization. 
The local actions interconnect leading to the emergence of a powerful 
phenomenon, but the interconnections are difficult to make because of organizational 
bureaucracy and silos (Uhl-Bien & Arena, 2017). Scholars of CLT addressed the central 
question of how organizational leaders enable the emergence of solutions to thrive in a 
complex and dynamic environment under a bureaucratic setting. The focus is to facilitate 
the transfer of ideas across a system by creating a link and brokering. Uhl-Bien and 
Arena noted that organizations consist principally of two systems; an operational system 
(drives formality, standardization, and business performance) and entrepreneurial system, 
which drives innovation, learning, and growth. The conflict emanating from the tension 
between the operational system for administrative efficiency and entrepreneurial systems 
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striving for learning, creativity, and growth is fundamental to innovation and adaptability 
(Mazzei, Ketchen, & Shook, 2017).  
Adaptive organizations enable adaptive space by enabling brokerage across 
various groups or acting as a catalyst to generate new ideas and promote the development 
and sharing of an idea in an entrepreneurial setting. There is an evolution in the 
regulation of each industry necessitating efficient strategies to manage relationships 
within and outside businesses because of enforcement by regulatory authorities (Riggs et 
al., 2016). Despite the abundance of research into leadership studies, researchers paid 
little attention to the regulation of businesses at the level of interactions between 
individuals in and outside of the business or even among followership (Mendes et al., 
2016). Understanding regulatory dynamics and providing guidance and interpretation 
within an organization are fundamental strategic skills that leaders in a regulated industry 
must cultivate and continually improve upon (Sravika et al., 2017). Byrne (2013) 
suggested that applying complexity theory to regulated organizations enables leaders and 
other agents to act, react and adapt based on their worldview, essential for successful 
registration and launch of products. The implication is that for any regulation, individual 
reactions and the sum of their actions are unpredictable and affect the success of such 
organizations (Caffrey et al., 2016). The sum of individual actions affects the trajectory 
of an organization; as such, Caffrey et al. noted that daily decisions or reactions to 
regulations influence the entire organization. Furthermore, successful people in a 
dynamic and regulated environment must develop and implement strategies that 
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encourage interactions among agents promote regulatory knowledge and skills of 
managers and employees within the organization.  
Enabling leadership. The enabling leaders in the CLT paradigm facilitate and 
enable the conditions in which an emergent event occurs. The emergent events and 
changes are not directly from the leaders but facilitate individuals within organizations 
that catalyze and function towards a common goal. Leaders enable the conditions in 
which an emergent event occurs, rather than a person and the change are not the direct 
from the leaders. Uhl-Bien et al. (2007) found that enabling leadership occurs across 
organizations and enabling behaviors more common among middle managers. Galuska 
(2014) noted the difficulty in creating the required environment conducive for engaging 
the leadership capacity of each individual in the system to optimize performance while 
continuing to meet the many administrative, regulatory, and financial requirement within 
the organization. The key elements of enabling leadership are: (a) the promotion of 
complex adaptive system dynamics that enable conditions that result in adaptive 
leadership and emergence, (b) the management of the entanglement of formal, top-down, 
administrative functions and informal, emergent, adaptive functions within organizational 
settings with different levels of complexity.  
Supporting and Rival Theories 
The focus in the new leadership development paradigm is the emphasis on social 
capital where interpersonal skill development for both the leader and followers is 
germane (Haslam et al., 2017). Dinh et al. (2014) revealed that scholars often focused 
much of their studies of leadership on individual leadership models geared towards the 
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style theories of leadership.  Researchers use the organizational learning theory to explore 
external influence on organizations is the organizational learning theory. Learning is 
critical for organizations to remain adaptive and how organizational leaders and followers 
learn is critical in addressing the challenge resulting from external turbulence for an 
emergent solution to evolve (Chadwick & Raver, 2015). The increasing level of 
turbulence, uncertainty, interdependencies, and interrelatedness is generating some levels 
of complexity placing key constraints on traditional or conventional leadership constructs 
(Clark, 2013; Uhl-Bien et al., 2007). Most leadership theories relate to individual leaders 
exercising interpersonal influence and power to gain commitments and motivation of 
others to achieve organizational objectives (Clark, 2013). Organization leaders must 
consider all resources and capabilities in their quest to be successful (Waddell & Pio, 
2015). 
Organizational learning theory. The core of organizational learning is the 
collective learning by members of an organization involving the discovery of relevant 
new knowledge and dispersing the knowledge to individuals in the organizations to 
improve internal processes and external adaptation (Ratnapalan &Uleryk, 2014). Scholars 
of complexity leadership theory adduce to the point that in a dynamic system, the need 
for leaders to align their strategies, structure, and process with its external environment as 
well as relationships are critical (Mthuli, Bodhanya, & Sobratee, 2017). Stettina and Horz 
(2015) noted that small groups and teams, such as project teams, committees, and top 
management team members perform much of the work in organizations.  
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Leaders can influence collective learning by encouraging and nurturing 
procedures that increase creative ideas and giving members opportunities to explore new 
approaches to performing a task (Chadwick & Raver, 2015). Complexity leadership 
scholars stress the importance of learning as a key ingredient of enabling leadership, 
which is a major component of complexity leadership theory (Horvat & Filipovic, 2017).  
Ratnapalan and Uleryk (2014) argued that in complexity theory, discussions about 
systems are difficult to address without focusing on the ability of the agents to learn. To 
understand the complex environment, there is the need to promote learning and 
organizational learning framework is a key factor for organizational competitiveness and 
survival (Chadwick & Raver, 2015).  
Over the past few decades, there is a growing acceptance among scholars of 
organizational learning as a business strategy (Palos & Stancovici Veres, 2016). 
Organizational learning is a mechanism of knowledge acquisition and organizations as 
social systems with a culture that promotes or impedes learning. The business aspect 
involves attaining competitive advantage through learning, psychological, and behavioral 
aspects of individual learning and cross-cultural comparisons of organizational learning 
(Mendes et al., 2016). Organization leaders focus on organizational learning to operate 
efficiently and maintain a competitive edge through creativity, innovation, and adaptation 
to change (Popova-Nowak & Cseh, 2015).  
Organizations leaders modify their organizations to acquire new knowledge 
through learning practices, creating a supportive learning environment that improves the 
learning skills of members who apply knowledge of such learning to modify strategies 
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(Onyema, 2014). The release of regulation or guidelines often lead to conditions of 
uncertainty (Riggs et al., 2016), and under conditions of uncertainty, team learning is 
paramount, contributing to the ability of agents in organizations to improve their 
aggregate understanding of a given situation. Team learning helps to accentuate the 
relevance of complexity leaders as a catalyst to learning.  
Complexity leadership scholars reinforce the importance of learning for 
adaptation, enables employees to perform and work towards the mission of the 
organization (Naqvi, Khan, & Butt, 2015). Given the challenges that leaders and 
followers face because of regulations in the pharmaceutical industry, learning within the 
organization offers an opportunity for developing a clear process for sustainability 
(Berson, Da'as, & Waldman, 2015). Motivation is a key element that influences 
employees learning and knowledge sharing within an organization as noted by Naqvi et 
al. (2015). Raina and Roebuck (2016) acknowledged the need for leaders to assign tasks 
understandably, communicate effectively, and use multiple channels of communication 
when dealing with subordinates. The thinking among organizational learning scholars is 
that by creating a culture of organizational learning, organizations can deliver on quality 
products and outcomes through continuous improvement from learning (Ratnapalan & 
Uleryk, 2014). Organizational learning affects the long-term sustainability of an 
organization with a collateral impact on various outcomes (Berson et al., 2015). 
Organizational learning theory is a conceptual framework used by scholars to 
understand how to improve a company’s performance through individual’s learning, 
which in turn affects groups and the entire organization (Santos-Vijande et al., 2012). 
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Organizational learning functions through learning mechanism of institutionalized 
structural and procedural arrangements, which promote the learning process (Cirella, 
Canterino, Guerci, & Shani, 2016). The mechanisms afford organization members the 
opportunity to gather, process, disseminate, and utilize data and knowledge relevant to 
the organization. The knowledge gained by members stays within the organization 
through the dissemination of lessons learned to various groups or units, even with 
changes in team members. Organizations perform different activities and functions 
designed to promote efficient learning (Seidel, 2015).  
Organizational learning involves the creation of new knowledge with influence on 
people’s behaviors relative to their work with ultimate impact on the performances 
resulting from the creation of new knowledge (Naqvi et al., 2015). Similarly, Ratnapalan 
and Uleryk (2014) found that learning has important implications for innovation 
processes, competitive advantage, growth, and profitability of the organization. Schilling 
and Kluge (2009) identified a series of barriers including behaviors as barriers to 
organizational learning that hinder organization members from adapting to the decision-
making challenges confronting them. Individuals remaining stagnant in an organization 
or position over a long period often find it difficult to learn. A key role of organizational 
learning is to foster efficiency and effectiveness required for organizations to be 
successful (Santos-Vijande et al., 2012). The role of organizational learning is critical 
because the learning and knowledge base of an organization results in a competitive 
advantage. Furthermore, Ratnapalan and Uleryk noted that organizational learning 
provides the setting for integrating the different agents and components into a united 
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policy to advance healthcare delivery. Organizational learning provides a framework for 
complex, interdependent dynamic systems where each component learns and performs its 
activities cooperatively for the production or delivery of desired products (Argote, 2013). 
Argote (2013) identified three sub-processes in the study of organizational 
learning including creating, retaining, and transferring knowledge. The appropriate 
decision strategies or processes need to align with the statutory guidelines that must 
include knowledge of clinical, safety, manufacturing, and pharmacovigilance 
requirements as enshrined in the guidelines. Company leaders must formulate strategies 
on how individuals learn regulatory agencies’ periodic reviews, safety updates, and 
adverse event reporting. Sieweke and Zhao (2015) developed a theoretical framework for 
analyzing organizational learning, with the core of the framework based on the 
interaction of organizational experience and the context leading to the emergence of 
knowledge. The introduction of organizational learning has spurred interest among 
practitioners and academics as a strategic concept to improve a firm’s success since the 
1980s (Waddell & Pio, 2015). Discussions on organizational learning theory emerged in 
the 1960s sequel to a change in the thinking among managers that organizations are 
organic systems emphasizing relationships between and within groups. The 
organizational learning philosophy stemmed from the seminal work of Cangelosi and 
Dill, which Argyris and Schon extended and Peter Senge popularized in 1990, gaining 
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widespread application in academics and practice (Hu, Found, Williams, & Mason, 
2014). 
Organization learning theorists lend credence to how organization members learn. 
Dasgupta (2011) identified the processes involved and key factors related to the concepts 
of organizational learning. The four key variables of how organizations learn include (a) 
its experience, (b) copied from others, (c) creation and promotion learning environment, 
and (d) what is involved in the development of a conceptual framework. Dasgupta (2011) 
further noted that organizational learning has both a weakness and opportunity for 
creating new standards in a dynamic business environment. Healthcare administrators 
avail themselves of the learning organization concept and promote collaborative learning 
among teams as they strive to improve patient safety (Corrigan & Curtis, 2017). Through 
organizational learning, companies can increase organizational effectiveness and 
efficiency through shared knowledge and understanding.  
Researchers also view organizational learning as a system of collective education 
with the capacity to transform operations, performance, and outcomes in healthcare 
organizations (Ratnapalan & Uleryk, 2014). Teams working in healthcare comprise of 
individuals with varied backgrounds working together to deliver the objective of the 
organization. Through organizational learning, different inter-professional team learning 
and systems-based organizational learning facilitate goals that are vital to managing the 
learning requirements in complex, interconnected dynamic systems. Five key aspects of 
the concepts and practices are collectivity of individual learning, systems, culture, 
knowledge management, and continuous improvement (Ratnapalan & Uleryk, 2014; Tan, 
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2015). Organizational learning is an ongoing phenomenon occurring through formal and 
informal learning that leads to organization change (Pallet & Chilvers, 2015; Ratnapalan 
& Uleryk, 2014).  
Organizational learning theory has inherent flaws. Senge focused on distributed 
leadership, which lacks cogent theories, neglects issues of practice and issues of power 
(Beauregard, Lemyre, & Barrette, 2015; Caldwell, 2012). Caldwell (2012) argued that 
one could conceptualize Senge’s learning organization as a limited mix of systems 
thinking and learning theories that result in a perception of organizational learning as a 
model of distributed leadership. Managers’ characteristics have high impact on the level 
of learning within a firm, but leaders who integrate both technical and administrative 
backgrounds promote higher learning among employees (van Hoof, 2014). Van Hoof 
recommended a blend of learning method and supply networks as a useful means of 
encouraging the implementation of company plans through organizational learning. One 
of the key elements of complexity leadership is the flexibility requirements for team 
members in organizations to adjust their activities due to changes in internal and external 
conditions of the organizations without affecting quality and safety of their products 
(Mendes et al., 2016). New regulatory requirements, new knowledge creation, technology 
advances, and market changes, for example, add new burdens to pharmaceutical 
companies, requiring that they comply with new regulations, organization policies, and 
procedures to incorporate new knowledge. Researchers’ understanding of organizational 
learning should grow with the continuation of research on current topics, particularly in 
areas of knowledge creation and organizational capabilities. Organizational forms and 
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technological developments will create both challenges and opportunities for 
organizational learning. 
In a modern dynamic industry, improving organizational culture is essential given 
the frequent changes in the business environment. Organizational culture comprises an 
amalgamation of goals, roles, attitudes, assumptions, communication practices, and more 
(Belias & Koustelios, 2014). Business organization processes include various activities 
and functions with the involvement of many stakeholders (Bauman & Siggelkow, 2013). 
The nature of the leadership within an organization defines the culture within it, but 
culture is the accumulated outcome of collective learning that begins with leadership 
(Shahzad, Luqman, Khan, & Shabbir, 2012). Culture is a combination of shared values, 
beliefs, and norms that affect the thinking, views, and behaviors of employees toward 
each other and to persons external to the organization (Giorgi, Lockwood, & Glynn, 
2015). Organization culture facilitates work attitudes and behaviors to improve the 
effectiveness of organizations (Liden, Wayne, Liao, & Meuser, 2014). Similarly, Belias 
and Koustelios (2014) noted that attitudes and behaviors in turn, influence the 
employees’ approach to the assimilation and manner of response to external factors and 
decision-making.  
To create a culture of organizational learning, organizations deliver quality 
products and outcomes through continuous improvement from learning (Ratnapalan & 
Uleryk, 2014). Tang and Yeh (2015) suggested that company culture, current skills, 
expertise, organizational structure, the motivation for learning, accommodations for 
steady change, and leadership all influence learning. Employees learn about the cardinal 
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values of organizations through signs, symbols, stories, ceremonies, organizational 
language, and social practices that affect the organization as it cultures matures (Shahzad 
et al., 2012). The core of organizational culture is that people are in the organization 
because each organization attracts and retains individuals with different personalities, 
values, and ethics. The synergy of four essential components defines organizational 
culture: (a) characteristics of the people associated with the organization, (b) 
organizational ethics, (c) organizational structure, and (d) nature of the employment 
relationship (Yukl, 2012). The activities of people in the organization result in 
organizations with different cultures, success, and failures (Belias & Koustelios, 2014). 
Improving organizational culture is a difficult quest for various organizations and their 
people (Yukl, 2012). If employees are committed and share similar value and norms as 
their organizations, the organizations achieve their overall goals (Shahzad et al., 2012). 
The leaders where the culture of organizational learning thrives have a supportive climate 
where employees’ ideas and initiatives blossom (Che-Ha, Mavondo, & Mohd-Said, 
2014). Leaders of such organizations also exhibit and foster a culture where members are 
tolerant of employee’s errors (Che-Ha et al., 2014).   
The global environment, defined by increasing complexity, uncertainty, 
nonlinearity, and accelerated change, is increasingly affecting new organizations. The 
literature on organizational learning, innovation, and culture traditionally connects these 
concepts through linear causality, with the assumption that any one of them is the cause 
of another, an approach that is static and contradictory to complexity theory approach 
(Chiva, Ghauri, & Alegre, 2014). Leaders in organizations face a high state of 
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complexity, and how leaders in those organizations handle these complexities is drawing 
the attention of scholars (Albert, Kreutzer, & Lechner, 2015). Leaders require adequate 
knowledge of the processes and how to relate with the stakeholders involved in the 
operations to make informed decisions about the requirements of activities (Proches & 
Bodhanya, 2015). Scholars are showing interest in the interactions among activities 
leading to the creation and sustenance of competitive advantage (Albert et al., 2015). 
The Congruence Model of Organizational Behavior 
Another competing theory I considered for this study as a guide for analyzing the 
course of action in this study is the Nadler-Tushman congruence model of organization 
developed in the early 1980’s by Nadler and Tushman (1980). Nadler and Tushman using 
the congruence model developed a roadmap to analyze organizations as consisting of 
interacting components, existing in congruence or fit with one another. Marino, Aversa, 
Mesquita, and Anand (2015) suggested that an organization is a system composed of 
interdependent parts or building blocks, components, or subsystems operating within an 
environment. Nadler and Tushman noted that problems arise in organizations when there 
is misalignment or lack of fit among components in the organization. Amis (2018) 
posited that in successful organizations, the leaders and followers must be able to respond 
to external forces affecting the company by redefining and reorganizing the company to 
be in harmony with the environment.  
The core competencies of successful organizations are the ability of the people in 
the organization to continually adapt to change and master the environment under the 
prevailing conditions (Smits & Bowden, 2015). Company executives, managers, and 
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employees position their organizations in a flexible state changing the shape of the 
organization in response to external influences (Harraf, Wanasika, Tate, & Talbott, 
2015). The components of organizations are (a) task, (b) people, (c) structure, and (d) 
technology. Nadler and Tushman developed the congruence model for team members to 
effectively respond to external disturbances on a company as scholars began shifting their 
focus from external planning to internal resources of organization (Seong, Kim, & 
Szulanski, 2015).  
The goal of Nadler and Tuschman (1980) was to develop a framework more 
useful as an analytical tool with emphasis placed on the transformation process and 
interdependence of components in organizations. Nadler and Tushman viewed 
organizations as consisting of components that interact with each other. The components 
attain a state of relative stability, consistency, or fit with each other. The elements of the 
company can fit together in a state of harmony leading to the efficient functioning of the 
company or loosely fit resulting in problems, dysfunctions, and poor organizational 
performance.  
The idea of congruence of components is traceable to the work of George 
Homans work on the social process in organizations highlighting the importance of 
interactions and consistency among critical components of organizational behavior 
(Hsiao & Chiou, 2017). Additionally, Nadler and Tushman (1980) drew from the works 
of other scholars including, Seiler, Lawrence, Lorsch, and Seldon. Nadler and Tushman 
submitted that Lawrence and Lorsch emphasized relationships between differentiation 
and integration each organization in response to environmental requirements and the 
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relative economic performance. As such, the key components of the Nadler-Tushman 
congruence model relate to the questions of: (a) inputs to the organization, (b) outputs the 
organization produces, (c) key components of the transformation process, and (d) the 
manner of interaction of the components (Nadler & Tushman, 1980).   
Toplis and Randell (2014) revealed that managers must understand their 
businesses from the four pillars of Nadler and Tushman model and, they must be 
sensitive to change, able to reorganize and redefine the company in line with external 
forces and demands to make them more efficient. Pharmaceutical companies consist of 
different related components, functioning in a state of harmony despite inputs from the 
environment to transform inputs into products (Almici, 2015). Using the Nadler-Tushman 
model, scholars posit that organizations exhibit key elements of systems theory, which 
provided a means of thinking about organizations as complex and dynamic (Seong et al., 
2015). The main characteristics of systems are: (a) internal interdependence, (b) capacity 
for feedback, (c) equilibrium, (d) adaptation, and (e) equifinality. Nadler and Tushman 
improved on the limit of system theory as a problem solving, which led to their 
formulation of a practical model based on the open system paradigm called the 
congruence model of organizational behavior.  
One of the challenges that managers in regulated industry is adapting the strategy 
of their organizations, and they must selectively adapt. Day and Shiemaker (2016) 
underscored the importance of selectively adapting and refining organizational 
capabilities in periods of rapid change. Amis (2018) noted the importance of leaders 
being able to position their companies such that the adaptation strategy does not 
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negatively affect their ability to respond to severe changes in the environment. 
Organization managers’ may successfully coordinate various resources within the 
organization for explorative and exploitative functions that may provide managers with 
new opportunities. Under the high regulation, there is little understanding of how leaders 
and managers coordinate various actions in response to regulatory requirements 
(Pilbeam, Doherty, Davidson, & Denyer, 2016). Leaders and managers in organizations 
are responsible for coordinating resource allocation, addressing the routine and changes 
emanating from inputs or environment. 
The concept of congruence and ambidexterity. According to Nadler and 
Tushman (1980), the concept of congruence model is a measure of the fitness of 
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as most effective when the components fit together, and this view in strategy extends to 
include the fit between organization and the environment (Wadongo & Abdel-Kadrr, 
2014). However, O’Reilly and Tushman (2013) argued that different organizational 
forms require different strategies and external inputs. O’Reilly and Tushman (2013) 
noted that companies operating in a turbulent environment require a change in structural 
alignments requiring managers to strike a balance between exploitation by focusing on 
existing viability and exploration for future existence. Tushman and O’Reilly (1996) 
posited that organizational managers create ambidextrous organizations to achieve the 
desired structural alignments. Junni, Sarala, Taras, and Tarba, (2013) added that 
ambidexterity has a positive impact on the success and survival of organizations, based 
on the ability to transform and adapt the organizations in the face of uncertainties.  
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Ambidexterity as a strategy is relevant in a turbulent environment. In the volatile 
and uncertain environment, ambidexterity helps organizations to maintain strategic 
flexibility through association existing environment and adaptive to a possible 
disturbance. Tushman and O’Reilly (1996) found that the ability of organization 
managers to address several activities within the organization concurrently was critical to 
the survival of such organization. In highlighting the importance of organizations 
operating in a turbulent environment, managers in such organizations need to develop a 
coordination mechanism consistent with the key theory of ambidexterity (Heracleous, 
Papachroni, Andriopoulos, & Gotsi, 2017).  
The regulatory demands imposed on healthcare organizations limit the speed of 
product development and market entry of pharmaceuticals and the success of such 
organizations (Redden, 2016). The pace of innovation in the pharmaceutical industry and 
the response of various regulatory agencies are creating turbulence that is forcing 
company managers and leaders to implement strategies leading to the adaptation of their 
companies at a faster rate (Redden, 2016). Dunlap, Marion, and Friar (2014) established 
that pharmaceutical companies in the face of turbulence and change adapt to through 
various forms of adaptation and ambidexterity. 
The Pharmaceutical Industry 
Pharmaceutical organizations are highly regulated in many markets; 
pharmaceutical products require regulatory approval for the development and distribution 
(Duggal, Kashyap, Singh, & Kakar, 2014; Liberti et al., 2016). The complex maze of 
regulations in the pharmaceutical industry affects every sector of pharmaceutical 
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companies, presenting fundamental obstacles to business activities and successful 
leadership (Riggs et al., 2016). Pharmaceutical companies belong to an industry where 
the core products affect the lives and well-being of the population (Palumbo et al., 2016). 
The pharmaceutical industry consists of organizations involved in any of the following 
activities: (a) research, (b) development, (c) manufacturing, (d) distribution, and (e) 
marketing of pharmaceutical products (Almici, 2015). The spending on these core 
products accounts for a significant proportion of the cost of healthcare (Hassali et al., 
2014), accounting for 20% to 60% in developing countries. Almici (2015) articulated the 
importance of the pharmaceutical industry to the economy of nations with a particular 
focus on the European pharmaceutical sector. The demand for medicinal drugs has forced 
stakeholders to demand higher scrutiny of pharmaceutical industry executives by 
regulators (Handoo, Arora, Khera, Nandi, & Sahu, 2012). The use of ineffective, low 
quality and adulterated pharmaceuticals results in deleterious health conditions to the 
public (Amadi & Amadi, 2014). The implications of Amadi and Amadi (2014) 
conclusion were the negative outcomes of ineffective pharmaceutical products influence 
the confidence of stakeholders in the healthcare system of a country. Individuals from 
multiple disciplines are the critical components of pharmaceutical organizations. All 
individuals are interdependent with one another within larger interconnected teams. The 
interdependence results in the development of safe and quality pharmaceutical products 
that satisfy regulatory and other stakeholder demands. The interdependence warrants that 
leaders and managers of pharmaceutical organizations need to be flexible to incorporate 
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changes in activities, particularly responses to a changing regulatory environment without 
compromising product quality (Seidel, 2015).  
Nigerian pharmaceutical market. Nigeria is a densely populated country with a 
population estimated to reach 207 million by 2020 (Business Monitor International, 
2016), indicating an increasing need for pharmaceuticals. The growing population is a 
serious challenge to stakeholders on the provision of high quality and cost-effective drugs 
(Ogbonna, Ilika, & Nwabueze, 2015). The country also has a high incidence of disease, 
poverty, malnutrition, and a growing pharmaceutical industry saddled with the provision 
of safe and effective products for this increasing population (Ogaji, Olawode, & Iranloye, 
2014). While reviewing capacity utilization in the pharmaceutical industry in Nigeria, 
Ogaji et al. (2014) noted the critical impact of the pharmaceutical industry on the 
healthcare system of the country particularly concerning essential drug supplies. 
Business Monitor International (2016) estimated that the Nigerian pharmaceutical 
market in 2016 was worth $905 million and projected value of $941 million by 2020. 
Nigerian pharmaceutical companies, contribute 60% of the pharmaceuticals to the 
Economic Community of West African States (ECOWAS). However, other ECOWAS 
countries such as Ghana are making efforts to increase their participation in 
pharmaceutical product manufacture (Akomea, Sorenson, & Amponsah-Efa, 2014). 
The Nigerian government has provided infrastructural incentives to the health 
sector for the last 20 years in an attempt to solve the problem of drug shortages in the 
country. Some of the incentives to promote the pharmaceutical industry were the 
establishment of agencies and task forces like the National Agency for Food and Drugs 
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Administration and Control (NAFDAC), Essential Drug List, and National Drug 
Formulary Acts (Ogaji et al., 2014). Nigeria’s poor pharmaceutical regulatory 
environment is a major hindrance to investment in the sector (Business Monitor 
International, 2016). The literature on pharmaceutical regulation in the sub-Saharan 
nations is sparse, and how leaders react to regulations affecting the pharmaceutical 
industry is still in its infancy. The emphasis in available publications was more on the 
politics of pharmaceutical regulation (Olugbenga, 2013). Similarly, other scholars in 
pharmaceutical regulations like Amadi and Amadi (2014) focused their studies on the 
regulatory agencies approaches to combating adulterated drugs without much discussion 
on the implications of regulatory changes on businesses. Nevertheless, Nigerian 
pharmaceutical industry leaders continued to operate on a difficult business terrain in an 
evolving regulatory landscape (Olugbenga, 2013). Nigerian pharmaceutical companies, 
as a reflection of other ECOWAS nations, are under a myriad of burdens directly linked 
to product registration issues, particularly in foreign markets (Akomea et al., 2014). 
Consequently, regulatory challenges were a critical drawback to sales expansion across 
borders in the region, which further explains the importance of regulations as a major 
driver of pharmaceutical companies’ successes in Nigeria and other ECOWAS countries, 
despite their search for wider markets.  
Interdependence in the pharmaceutical chain. The pharmaceutical product 
chain is complex, often with different agents and components involved before reaching 
the end user of the product, creating both opportunities and challenges to company 
leaders (Almici, 2015). According to Almici (2015), the main stages involved in 
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providing pharmaceutical products to consumers as articulated are (a) the development 
stage, involving the selection of products to develop, the population, and the disease state 
to target; (b) registration and marketing authorization required in different markets before 
the introduction of pharmaceutical products into markets; (c) the manufacturing process, 
involving the production of pharmaceutical products according to set standards and 
procedures; and (d) distribution aimed at regular supply and storage of pharmaceutical 
product in good conditions to end users and minimizing losses due to spoilage and 
expiry. 
 Interdependencies among agents at various stages of the value chain affect the 
strategy and business decisions of pharmaceutical leaders (Caffrey et al., 2016). The 
processes or activities involved in the management of a successful pharmaceutical 
company leading to a steady supply of products comprised of a complex interrelationship 
among the agent and components, both internal and external (healthcare professionals, 
employees, regulatory authorities, vendors, and researchers). Managing agents and their 
interactions or interconnections in an organization are crucial in a complex organization 
(Silva, Silva, & Leite, 2016). The relationship among the agents is relevant for the 
emergence of desired outcomes, as leaders must rely on the functioning and efficient 
management of relationships to achieve the desired result. Silva et al. (2016) highlighted 
the importance of effective management of agents and activities within a healthcare 
delivery system. Agents need extensive knowledge and experience accumulated during 
professional exercises and through managerial practices to facilitate smooth interactions 
(Proches & Bodhanya, 2015). 
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Challenges and opportunities often accompany the introduction of pharmaceutical 
products into any market and opportunities with a projection of improved healthcare 
delivery, reduced costs to consumers, and social change (Brodszky, Baji, Balogh, & 
Péntek, 2014). The complexities of the manufacturing process, complexities of 
performing clinical work, and adhering to regulatory agencies guidelines are some of the 
challenges to overcome (Clancy, 2015). However, in many developing countries, the 
healthcare industry is still in its infancy and not well organized as in advanced economies 
like the United States, EU, Japan, and Canada. Hence, knowing and complying with 
regulations in those regions of the world are challenging to both local and international 
pharmaceutical company leaders and other stakeholders (Olugbenga, 2013; Van Norman, 
2016).  
Pharmaceutical regulatory framework. Regulations are an array of rules that 
affect individuals and organizations, which governments use to maintain a balance 
between the benefits and risks of new therapeutic products (Sorenson & Drummond, 
2014). Pharmaceuticals are among the most heavily regulated products, with many 
regulations in place to protect the health and well-being of the population (Handoo et al., 
2012). Because governments at all levels are responsible for protecting their populations, 
they will often use regulations as the tool to achieve this responsibility. Regulations are 
also tools that governments and their agencies deploy to accomplish the goal of licensing 
safe, effective, and high-quality therapeutic products (Balasubramanian, Muthukumaran, 
Hariram, Nandhini, & Saisugathri, 2016). The tight weave of regulatory and business 
activities necessitates a high-level review of complex decisions critical to the success of 
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pharmaceuticals and organizations in highly regulated industries like pharmaceuticals 
(Naghshineh et al., 2014). Regulatory authorities also use guidelines to control 
Pharmaceuticals at every stage of the pharmaceuticals chain (Balasubramanian et al., 
2016).  
 Governments establish laws, regulations, and effective national regulatory 
authorities to ensure that the manufacture, distribution, and use of pharmaceuticals by 
citizens are safe (Maynard & Bloor, 2015; Ogbonna et al. 2015). The rise and rapid rate 
of change in regulations implied that leaders in a highly regulated industry like the 
pharmaceutical industry would need to remain current on regulatory guidelines to ensure 
complete compliance. Business leaders must also understand the impact of regulations on 
their business environment to assess potential threats and opportunities in decision-
making (Riggs et al., 2016), while Anyakora et al. (2017) submitted that regulations 
influence the availability, affordability, and quality of pharmaceuticals.  
To perform efficient regulatory control, governments often deploy regulatory 
tools through specialized agencies to protect consumers in most commercial activities, 
including telecommunications, energy, financial, food, tobacco use, healthcare, and the 
environment. Examples of government efforts to protect citizens using regulations 
include the financial regulations stemming from laws enacted in many countries to 
address the cause of the problems in the banking sector following the global financial 
crisis of 2007-2009 (Thakor, 2015). Another example was the 2009 Affordable Care Act, 
enacted in the United States to increase access to affordable healthcare (Lu, 2014). The 
ultimate rationale for regulating commercial activities was to overcome market failures, 
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inefficiencies, monopolies, and protect consumers, and these objectives apply to 
pharmaceutical regulations (Lu, 2014; Mourlon-Druol, 2016). 
The requirements for company leaders to comply with rules stem from (a) 
legislative and regulatory agencies (e.g., the Sarbanes-Oxley Act, and Affordable Care 
Act 2009), (b) industry standards and codes of practice (e.g., ISO 9000, IEEE), and (c) 
business partner contracts. Business leaders continue to struggle to comply with mandates 
and timelines required by these mandates. Understanding regulatory dynamics is one of 
the key strategies needed for organizational leaders to be successful and efficient in 
satisfying stakeholders’ demands while complying with regulatory requirements 
(Malerba & Orsenigo, 2015).  
The regulations of pharmaceuticals are fraught with challenges, including issues 
of manufacture, quality, safety, and tolerability (Mintz, 2015). Regulators use evidence-
based approaches to regulations consisting of technology assessment to verify claims 
relating to the safety, efficacy, and cost-effectiveness of therapeutic products (Sorenson 
& Drummond, 2014) that further constrain company leaders. Many leaders are unsure 
how to engage with or relate to regulatory agencies, neither understanding the details in 
the regulation of interest nor the benefits of using a particular regulatory process 
(Broekhuizen, Groothuis-Oudshoorn, van Til, Hummel, & Ijzerman, 2015). Lack of 
understanding may result from the drug regulatory agencies saddled with the 
responsibility for regulating drugs, devices, foods, and cosmetics in their countries. The 
responsibilities of agencies like the US Food and Drug Administration (FDA) and the 
Nigeria National Agency for Food and Drug Administration and Control (NAFDAC) are 
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similar to those of several other government agencies, but the resources and demands of 
each agency are different (Handoo et al., 2012). Stakeholders, including manufacturers, 
distributors, and consumers, find it frustrating and confusing to determine which 
regulatory agency and how to engage regulators in obtaining market approval for their 
pharmaceutical products (Broekhuizen et al., 2015). 
Pharmaceutical regulatory systems.  Most countries have established 
pharmaceutical legislation and regulatory requirements for the development, and market 
approval for the introduction of pharmaceutical products into their countries 
(Balasubramanian et al., 2016). While reviewing regulatory guidelines, Balasubramanian 
et al. (2016) stated that the level of sophistication in the requirements and depth of items 
required for each country varies, depending on the level of their socio-economic 
development. The requirements may be in the form of dossier submission for the 
complex requirements to a simple notification letter to gain approval (Duggal et al., 
2014). These requirements formed the basis for leaders to have individuals available who 
can analyze and understand the commonalities and differences in the requirements of 
each country if they are to succeed in this era of globalization (Duggal et al., 2014).  
In developed economies like the United States, EU, Japan, and Canada also 
classified as regulated markets; regulations are well structured and clear. The rest of the 
world such as Brazil (Latin America), Tanzania (Africa), Russia, and others are emerging 
markets (Handoo et al., 2012). Regulated markets have defined regulatory requirements 
and regulatory agencies that ensure the agencies regulate the manufacture and 
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distribution of pharmaceuticals under strict quality standards to protect consumers in the 
entire pharmaceutical products chain (Parvizi & Woods, 2014).  
The concerns about the pharmaceutical industry developing medicines without 
addressing genuine unmet needs, performing research without due consideration for 
research participants, unsubstantiated claims, withholding negative results, adverse 
events, abuse of intellectual property laws, and off-label marketing practices has resulted 
in high regulation of the industry via a rigorous registration process for drugs (Schramm, 
Herbst, & Mattie, 2014). Hence, the ability of medical product manufacturers to 
formulate a balanced regulatory strategy is expedient for conducting a fair review of 
medical products leading to improved understanding of the medical product development 
and approval processes (Bujar, McAuslane, Walker, & Salek, 2017).  
In many markets, gaining approval or licensing of pharmaceutical products 
depends on the company capabilities gained from the performance of similar 
pharmaceutical products (Yousefi, Mehralian, Rasekh, & Yousefi, 2017). Studies on the 
decision-making process in the pharmaceutical industry have centered principally on 
research and development (Pace, Pearson, & Lipworth, 2015). Decision-making in the 
pharmaceutical industry is rife with uncertainty and decisions about what drug to develop 
or market and is an important organizational element that requires input from regulatory 
persons in the organization (Jekunen, 2014).  
The process of regulatory decision-making is the approach that leaders adopt in 
regulated organizations involved in pharmaceuticals to conform to regulatory 
requirements. The term process relates to the how and is an essential component of a 
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company resource that helps eliminate non-essential uncertainties from a plan (Dinh et 
al., 2014). The concept of regulation implies a specific array of instructions, deliberate 
government interventions, or socioeconomic controls designed to prevent or restrict 
unacceptable acts, activities, and processes (Baldwin et al., 2012). Society today is more 
industrialized, richer than at any other time, and more regulated from every aspect of 
human activity with different theories on the impact of regulation on economics, health, 
and social progress of countries in Western Europe and North America (Baldwin et al., 
2012).  
Scholars from a host of fields, including law, economics, political science and 
public policy, sociology, healthcare, management, and social administration engineered 
discussions on regulation (Baldwin et al., 2012). Likewise, scholars and industry 
professionals have written on various aspects of regulations including concepts, 
challenges, and suggestions, but the literature on leadership in pharmaceutical companies 
functioning in a wave of regulations is still evolving. Researchers in the fields of 
economics and political science often associate regulation with efficiency, accountability, 
transparency, and high productivity, with social welfare implications (Baldwin et al., 
2012). These criteria may lead to wealth creation and are an integral part of economic 
theories of regulation classified into two broad groups: (a) public interest theories of 
regulation and (b) private interest theories of regulations. On the contrary, Dechezlepretre 
and Sato (2017) argued that regulations cause substantial reductions in the growth of 
output and effect on labor and capital. 
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The reason for the rising interest in pharmaceutical regulation may not be 
universal but a result of peculiar needs of the market (Amadi & Amadi, 2014). Amadi 
and Amidi (2014) stated that counterfeit drugs as the primary reason for the interest in 
national pharmaceutical regulation in developing countries. This contrasts with the highly 
regarded regulatory systems in the EU, United States, Canada, and Japan, where the rise 
in regulation is the result of new product development and their contribution to healthcare 
outcomes (Macdonald et al., 2015). The increase in regulatory activities affects drug 
development phases as well as various agents and choices made about regulatory 
decisions (Herwig, Garcia-Aponte, Golabgir, & Rathore, 2015). As a result, having 
knowledge of a business environment and the impact of regulatory decisions on product 
positioning are vital to a product's performance in the market (Mehralian, Nazari, 
Akhavan, & Reza, 2014). Likewise, in-depth knowledge of regulations by company 
leaders or their designee and their motivation to embrace regulatory changes 
companywide saves time and errors in drug approval submissions or licensing 
(Naghshineh et al., 2014). 
Drug approval process. The FDA, European Medicines Agency (EMA), 
National Agency for Food and Drug Administration and Control (NAFDAC) are the 
agencies responsible for the evaluation of drugs developed by pharmaceutical companies 
for use in the United States, EU, and Nigeria respectively and for granting of marketing 
authorization to pharmaceutical companies (NAFDAC, 2016; Naghshineh et al., 2014). 
Pharmaceutical products require regulatory clearance before introduction into markets for 
the safety of the populace and various government agencies regulate all aspects of the 
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product lifecycle (Bedi, Krishan, & Singh, 2017; Warier & Mehta, 2016). Regulations for 
market access, manufacturing, and advertising are critical because of the need to protect 
the safety and efficacy of products. To highlight the importance attached to 
pharmaceutical products, many countries have developed a drug registration system that 
involves licensing and inspection of manufacturers and importers of pharmaceuticals for 
sale (Balasubramanian et al., 2016).  
Regulatory agencies are responsible for the scientific evaluation of medicines for 
use in their markets to satisfy the following criteria: (a) efficacy, (b) safety, (c) quality, 
and (d) clinical use information (Warier & Mehta, 2016). The licensing or market 
authorization process for pharmaceutical products is a critical component of 
pharmaceutical laws in most countries. The registration of pharmaceuticals in resource-
limited countries is often to ensure reliable product flow from reputable manufacturers 
and distributors (Amadi & Amadi, 2014; Olugbenga, 2013). Warier and Mehta (2016) 
found a lack of uniformity in regulatory approval among leading national medical 
product regulatory agencies. 
Although each country or market has an approval process designed for the needs 
and resources of that country, each country’s regulatory process evolved differently in 
accordance with requirements and resource availability (Parvizi & Woods, 2014). Each 
of the stages of the drug approval process has multifaceted requirements, which sponsors 
must fulfill to advance to the next stage in the approval process (Handoo et al., 2012). 
The requirements contribute significantly to the high cost of drug development or 
marketing in a particular market. Pharmaceutical products already approved in countries 
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with developed regulatory systems, as obtained in the United States, EU, Canada, and 
Japan often require less documentation to gain market authorization in other countries 
(Balasubramanian et al., 2016). A broad overview of the regulatory process for the 
approval of pharmaceutical products is provided in Figure 1. 
 
Figure 1. Overview of the regulatory processes in pharmaceutical licensing. 
Many of the drug approval processes in the EU are similar to those of the United 





















Figure 2. Typical drug approval procedure in the United States. 
The evolution of Nigerian pharmaceutical regulations. The National Agency 
for Food and Drug Administration and Control (NAFDAC) is the agency charged by the 
national government to regulate drugs in Nigeria (Amadi & Amadi, 2014). The National 
Agency for Food and Drug Administration and Control Decree Number 15, 1993 
established the agency, and functions to regulate food, drugs, cosmetics, and medical 
devices. The interest in the formation of a drug regulatory agency in Nigeria began in 
1988 following the promulgation of the Counterfeit and Fake Drugs Decree No. 21 of 
1988 to combat the growing problem of fake drugs (Ofuani, Kuye, & Ogundele, 2015). 
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NAFDAC has nine primary functions as contained in the NAFDAC Act (Food and Drug 
Administration and Control, 2016) including: 
  Conduct appropriate tests and ensure compliance with standard specifications 
designated and approved by the Council for the efficient control of the quality of 
food, drugs, cosmetics, medical devices, bottled water, chemicals and their raw 
materials as well as their production processes in factories and other 
establishments. 
  Undertake appropriate investigations into the production premises and raw 
materials for food, drugs, cosmetics, medical devices, bottled water, and 
chemicals and establish appropriate quality assurance systems, including 
certificates of the production sites and the regulated products. 
 Undertake inspection of imported food, drugs, cosmetics, medical devices, bottled 
water, and chemicals and establish relevant quality assurance systems, including 
certification of the production sites and the regulated products.  
 Compile standard specifications and guidelines for the production, importation, 
exportation, sale, and distribution of food, drug, cosmetics, medical devices, 
bottled water, and chemicals.  
The establishment of various regulatory agencies reinforced the revelation that 
Nigerian government has the responsibility to protect the people by ensuring that 
pharmaceutical organization leaders and followers to ensure compliance with regulatory 




In Section 1, I introduced the topic, problem statement, and purpose of this study. 
The general business problem is that noncompliance with regulation has a negative 
impact on company revenue, loss of brand value, product development, product approval, 
and regulatory investigations. As such, some pharmaceutical company managers lack 
strategies to ensure compliance with regulatory requirements. The conceptual framework 
for this study hinges on complexity leadership theory based on the work of Uhl-Bien et 
al. 2007. Researcher use complexity leadership theory to understand interactions, 
uncertainty, and unpredictability in organizations that arise from multiple interactions. 
The literature review component revolved around three themes namely, complexity 




Section 2: The Project 
In this study, I explored strategies that managers in pharmaceutical companies 
use to ensure compliance with regulatory requirements. Using a single case study, I 
explored the strategies the managers in the company use to be successful in Nigeria. In 
Section 2, I present a detailed approach to the methodology and data collection processes 
I followed and the technique to ensure quality in data gathering and analysis. As the 
primary researcher, I identify the research method and design to accomplish the purpose 
of the study after an in-depth review of scholarly articles and seminal sources. I justify 
the selection of research participants, describe my role as the researcher in the study 
process, and the selection of the population, sampling technique, and sample size. Lastly, 
I discuss the ethical approach to the research study, the data collection and data 
organization process, the analysis process, and my approach to ensure reliability, and 
validity of the study. 
Purpose Statement 
The purpose of this qualitative single case study was to explore strategies that 
managers in pharmaceutical companies use to ensure compliance with regulatory 
requirements. The target population for this study consisted of four pharmaceutical 
managers in a Nigerian pharmaceutical company who have successfully implemented 
strategies for compliance with the regulatory requirements in Nigeria. The implications 
for social change include the potential to improve the abilities of managers to ensure 
compliance in a regulated environment, which might lead to increased access, 
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availability, and affordability of pharmaceutical products by individuals with limited 
access to good healthcare. 
Role of the Researcher 
The researcher in a qualitative study functions as the primary instrument for 
collecting data through interviews, field observations, and document analysis (Yin, 
2014). Stake (2013) noted that the researcher is the key driver of the study, whereas 
Docherty (2014) posited that the researcher is responsible for selecting and shaping the 
theoretical concept of the study. My role as the primary researcher was to design the 
study, select research participants, and to provide them with information about the 
research process. In addition, I collected and analyzed the data. 
Roulston and Shelton (2015) noted that a researcher should be familiar enough 
with the study area to understand the central concepts and methodological concerns 
relevant to the study. As the primary researcher, I have worked in the pharmaceutical 
sector for the past 9 years in various capacities. Presently, I perform regulatory functions 
while serving to ensure compliance with various government regulations. My role in 
international regulatory affairs is to provide regulatory support within the organization 
for the registration and maintenance of the company products and facilities with 
appropriate regulatory authorities. As the researcher, my contacts with business leaders 
and pharmaceutical industry managers afforded me insight into the nature of those that I 
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recruited as participants because of my involvement in international regulatory issues in 
the pharmaceutical/medical industry. 
The Institutional Review Board (IRB) required researchers to adhere to the IRB 
regulations when conducting research (Tsai, 2013). I followed the guidelines of the 
Walden University IRB, and the ethical principles and guidelines for the protection of 
humans as outlined in the Belmont Report. The three basic ethical principles in the 
Belmont Report include respect for persons, beneficence, and justice (Miracle, 2016). 
The Belmont Report protocol provides researchers with information to protect the rights 
of research subjects or participants (Kawar, Pugh, & Scruth, 2016). In complying with 
the principles of the Belmont Report, researchers obtain informed consent, assess risks 
and benefits, and select participants. The informed consent process includes disclosing 
information about the research study, ensuring participants’ comprehension of the 
information, and emphasis on voluntary participation (Miracle, 2016). As the researcher, 
I conformed with (a) the ethical principles of the Belmont Report, (b) the guidelines of 
Walden University IRB, and (c) the ethical standards of the company. As such, I ensured 
that I ethically conducted this research by commencing data gathering only after 
receiving IRB approval. I explained the principle of informed consent to participants and 
obtained the signed informed consent forms before starting the data collection. In 
addition, I safeguarded participants’ identities, provided participants the informed 
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consent form, and treated all participants fairly and equally. Lastly, I ensured the highest 
ethical standards, including not plagiarizing or falsifying data. 
Evers, Hiligsmann, and Adarkwah (2015) noted that bias might occur in a 
research study at the planning, data gathering, data analysis, or presentation stage. A 
researcher’s understanding of bias is critical because this helps the researcher to evaluate 
the literature critically to minimize potential errors in the study. Malone, Nicholl, and 
Tracey (2014) advised researchers to minimize systemic bias while trying to eliminate a 
specific bias. Researchers introduce member checking in their research design to avoid 
bias (Elo, Kaariainen, Kanste, Polkki, Utriainen, & Kyngas (2014). To mitigate research 
bias, I designed and adhered to an interview protocol (Appendix A) and used member 
checking in the research design. By following the interview, protocol helped me to ensure 
that I treated all participants equally, sensitive to contrary views and did not allow my 
views to influence those of participants.  
Researchers use interview protocols in qualitative studies for data consistency and 
reliability (Baskarada, 2014). A good interview protocol enables the interviewer to gain 
insight into participants’ lived experiences and learn their opinions (Jacob & Furgerson, 
2012). The interview protocol enhances the reliability of a study as it includes an 
introduction, purpose, prompts, interview questions, and a blueprint of the case study 
report, case study questions, and references (Baskarada, 2014). Researchers using 
interview protocol to collect data can conduct their research by speaking with other 
individuals, a factor that may lead to a better understanding of the human condition. I 
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used the interview protocol to guide me through the interview process and ensured that 
all participants received the same information from me as the researcher. 
Participants 
The choice of participants in a research study affects the success and validity of 
that study (Marshall & Rossman, 2016; Yin, 2014). Researchers establish eligibility 
criteria in a study to ensure that participants have the requisite insight sought in the study 
and indicate their interest to participate (Rengerink et al., 2017). Participants in this study 
were managers who have successfully managed or demonstrated effective coordination of 
regulatory activities within the selected pharmaceutical company in Nigeria. In this case 
study, the participants were members of a leading indigenous, publicly traded 
pharmaceutical company with significant supervisory responsibilities for managing 
individuals to achieve the who have leadership roles and other responsibilities in the 
company value chain, particularly with regulatory responsibilities.  
Gaining access to initial contact with participants in qualitative research is 
essential to the goal of a study (Keshavarz, Ftahikenari, Rohani, & Bagheri, 2014; 
Peticca-Harris & de Gama, 2016). In a qualitative study, a few gatekeepers may be the 
principal obstacles to accessing key participants that have relevant information (Peticca-
Harris & deGama, 2016). Collaborating with the gatekeepers and having an in-depth 
knowledge of the desired populations are ways to overcome the challenges gatekeepers 
pose (Anuruang, Davidson, Jackson, & Hickman, 2015). I worked around the gatekeepers 
by leveraging my professional relationships and discussing my study with acquaintances 
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who have direct access to the senior executives of the company to gain access to the 
company.  
Researchers need to develop healthy relationships with potential participants to 
gain their confidence because interviewing requires building a relationship with the 
interviewee (Haahr, Norlyk, & Hall, 2014). Gaining participants’ trust is critical to 
building and maintaining a working relationship with the participants and enhancing their 
willingness to participate in the research (Andrighetti, Semaka, & Austin, 2017). 
Seidman (2012) posited that contacting each participant directly through their 
organizations before starting the interview would assist in building the groundwork for 
the actual interviews. Bristol and Hicks (2014) noted that providing participants with 
informed consent forms helps in gaining participants’ trust. Upon gaining access to the 
company, I recruited the participants through targeted direct email correspondence using 
the channels provided by the corporate affairs unit. The email contained a description of 
the intent of the study and sufficient information to help prospective participants to 
decide whether to participate in this study. I assured participants that the interview would 
not place them in a vulnerable situation that may jeopardize their positions or harm their 
ability to perform their jobs.  
Research Method and Design  
Three methods are potentially available for conducting research: qualitative, 
quantitative, and mixed-method (Yin, 2014). Following Yin’s (2014) work on case study 
designs, I determined that the qualitative method was the most appropriate for exploring 
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the strategies pharmaceutical company leaders use for compliance with regulatory 
requirements.  
Research Method 
The research method may be any of the following three methods: quantitative, 
qualitative, or mixed method (Marshall & Rossman, 2016). I performed a qualitative 
single case study for gathering in-depth information from participants to explore the 
strategies that managers use to ensure compliance with regulatory requirements. Research 
scholars emphasized the importance of a detailed literature search before deciding on the 
research method for a study (Baskarada, 2014).  
Qualitative researchers study phenomena using open-ended questions that provide 
rich and nuanced information based on participants’ experiences, perceptions, and history 
in their natural setting (De Massis & Kotlar, 2014). The emphasis of qualitative research 
is based on perceptions and experiences taken from only a few participants; hence, the 
outcome of the study is not generalizable to an entire population (Grosse, Dixon, 
Newmann, & Glock, 2016; Starman, 2013). Because the qualitative method allows for 
open-ended interview questions, the research participant is not constrained and is allowed 
to capture the often-neglected information (De Massis & Kotlar, 2014). Qualitative 
research is subjective, and the key focus is on participants’ perceptions and experiences 
relevant to exploratory study (Starman, 2013). The qualitative method will enable me to 
collect information on participants in their natural settings and learn about their 
individual experiences and interpretations.  
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Qualitative method researchers seek to understand the circumstances associated 
with activities, processes, and interactions in shaping and reshaping phenomena (Patton, 
Hong, Patel, & Kral, 2017). Researchers employ the qualitative method to explore 
underlying reasons that managers choose a particular knowledge set (Yin, 2014). Other 
justifications for the choice of qualitative method include a researcher’s ability to explore 
various situations and mechanisms in an organization or circumstance. With qualitative 
data, researchers can improve the description and explanation of complex concepts in a 
clear and concise manner (Bradley, Curry, & Devers, 2007). De Massis and Kotlar 
(2014) explained that researchers use qualitative methods for an in-depth understanding 
of issues, which is appropriate for exploratory questions Similarly, De Massis and Kotlar 
(2014) stated that the qualitative method is suitable for events where the number and 
observations available do not readily lend itself to consistent measurement and statistical 
analysis. 
Researchers use quantitative methods for research that involves statistical data, 
measurements, sampling, and analysis of relationships between variables (Bernard, 
2013). Quantitative researchers seek to count occurrences, establish a statistical 
connection among variables, and generalize findings from a sample to an entire 
population (Counsell, Cribbie, & Harlow, 2016). The quantitative method was not 
appropriate for this study because the study did not involve the testing of hypothesis or 
building of theories.  
Mixed method is a methodology for conducting research involving quantitative 
and qualitative methods in a single study to collect and analyze data when one a single 
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method is insufficient for researchers to understand a phenomenon (Dumbili, 2014). The 
mixed method approach requires time and resources for data collection and processing 
(Venkatesh, Brown, & Sullivan, 2016). Mixed method was not suitable for this study 
because the purpose of this study was not to combine quantitative and qualitative 
methods to understand a phenomenon. 
Research Design 
The research design is a plan that serves as a guide to researchers in the process of 
data collection, analysis, and interpretations (Yin, 2014). The study design influences the 
conclusions drawn from a study (Proches & Bodhanya, 2015). Qualitative researchers 
can choose from a plethora of possibilities that include case study, phenomenology, 
ethnography narrative, and grounded theory shared across the social and health sciences 
(Yin, 2014). The most appropriate research design for this study was the single case 
study. Case study may be a single or multiple case and can be explanatory, descriptive, or 
explanatory (Stake, 2013; Yin, 2014). I used a single case study design in this study to 
gain a deeper understanding of the phenomena in response to the research question. The 
rationale for selecting one pharmaceutical company was to explore the strategies that 
managers in the pharmaceutical company use to ensure compliance with regulatory 
requirements. The justifications for the choice of single case study included studying a 
critical case, an extreme case, a representative or typical case, and, revelatory or 
longitudinal case (Yin, 2014). 
Case study involves an in-depth data collection from various sources of 
information including interviews, observations, documents, field notes, and audiovisual 
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materials (Yin, 2014). Case study design affords researchers the opportunity to collect 
data in their natural settings through multiple sources of information such as interviews, 
observations, documents, and note taking (Morgan, Pullon, Macdonald, McKinlay, & 
Gray, 2017). Qualitative research scholars posited that the purpose of a case study is to 
provide insightful descriptions of an individual system, phenomenon or situation using 
qualitative and quantitative methods for data gathering and analysis (Stake, 2013; Yin, 
2014). 
Organizations benefit from the rich, holistic descriptions of a phenomenon in its 
natural state with the use of a case study design (Hyett, Kenny, & Dickson-Swift, 2014). 
Case study has the distinct advantage of generating robustness by advancing the 
knowledge and understanding of specific phenomenon while providing in-depth feedback 
to research questions (Morse & McEnvoy, 2014). Case study was suitable for this study 
to gain an exhaustive understanding of participants’ experiences in organization 
processes and business transformation. Yin (2014) made an argument for case study 
when the heart of the study hinges on how and why questions.  
Two factors are important in a case study: the number of cases in the study and 
the number of units of analysis. Stake (2013) noted that the nature of a case study may be 
intrinsic (unique), instrumental (improve), and collective (for generalization). The unit of 
analysis of the study relates to a phenomenon occurring in a confined framework (Yin, 
2014). The case of this study involved compliance with regulatory requirements in a 
pharmaceutical company, and the unit of analysis were managers in a pharmaceutical 
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company involved directly or remotely in any aspect of the pharmaceutical product's 
chain. 
Researchers use ethnographic or phenomenological design in qualitative business 
research (Yin, 2014). In an ethnographic study, the focus of the researcher is on beliefs, 
behavioral pattern, and culture of a group of people (Ferguson, 2016). Ethnographic 
researchers conduct their study by observing what participants are doing and saying, or 
participate by following participants wherever they go or do their biddings (Ingold, 
2014). The sources of data are from sources such as participants’ observation, field notes, 
and interviews (Gioia, 2014). Ethnography was not appropriate for this study because my 
focus was not on the culture of the people.  
In phenomenology, the researcher investigates lived experiences of individuals to 
understand the universal and underlying context of a phenomenon (Gill, 2014). 
Phenomenology researchers focus on the description of the experiences of participants 
and is suited for studies where collected data was from lived experiences of the 
participants (Cassel, 2017). I did not select phenomenology for this study given that I did 
not seek to explore lived experiences of those going through a phenomenon.  
Data saturation in a qualitative study is the point in data analysis where the 
collection more data will not result in additional information related to the research 
question (O’Reilly & Parker, 2013). Factors including the purpose of the study, 
population, research design, method of analysis, and available resources influence sample 
size (Hennink, Kaiser, & Merconi, 2017; Malterud, Siersma, & Guassora, 2015). 
According to Fusch and Ness (2015), data saturation occurs when no new themes emerge 
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from the data gathering. I ensured data saturation at the stage where the data collection 
process became counter-productive and until the interview data from participants became 
repetitive. 
Population and Sampling  
The population of this study was functional managers from regulatory, operations, 
distribution, and marketing departments from a pharmaceutical company based in 
Nigeria. Purposive sampling is suitable for selecting participants given the convenience, 
access to participants, and contributions to identifying participants with valuable 
information (Lucas, 2014; Palinkas, Horwitz, Green, Wisdom, Duan, & Hoagwood, 
2015). Researchers use purposive sampling to explore and to collect a variety of data 
based on the experiences of selected participants, with the assumption that participants 
will provide a significant amount of information related to the topic (Bernard, 2013; Roy, 
Zvonkovic, Goldberg, Sharp, & LaRossa, 2015). I used purposive sampling to select 
participants from the population. Bernard (2013) noted that, with purposive sampling, 
researchers could recruit participants with an experience that is specifically related to the 
study and in a situation where the number of participants was limited. The use of the 
purposive method to recruit participants ultimately ensures that a qualitative study results 
in the collection of data relevant the topic (Suen, Huang, & Lee, 2014). 
Researchers are not unanimous on the sample size for qualitative research, but 
most scholars suggest that data saturation is a key determinant of sample size (Hennink et 
al., 2016). A small sample size affords the researcher the benefit of analyzing the 
complexities of the data by providing better and richer insight into a phenomenon 
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(Galvin, 2015). I interviewed 4 participants until I reached saturation and no new themes 
or information emerges. Dworkin (2012) noted that 5 to 50 participants in qualitative 
research are adequate whereas O'Reilly and Parker (2013) strongly opposed the use of 
saturation as a marker of sample size.  
Fusch and Ness (2015) stated that failure to reach data saturation in qualitative 
research influences the overall research quality and suggested that researchers consider a 
research design that is explicit about data saturation. Researchers attain data saturation in 
their studies when; ample information is available to repeat their studies, and the ability 
to obtain more data and further coding are not achievable or practical (Fusch & Ness, 
2015; Morse, 2015). In addition, presenting the same questions to multiple research 
participants leads to data saturation (Malterud et al., 2015). I ensured data saturation by 
interviewing participants until data became repetitive. 
Researchers focus on the selection of participants to ensure that they have those 
individuals who can provide accurate information about the topic of study (Bernard, 
2013). The participants had the knowledge and expertise on how leaders and managers 
ensured compliance with the regulation. Participants provided the interview locations 
within the company facility, where they felt most comfortable without distraction during 
the interview process. Earp, Mitchell, McCarthy, and Kreuter (2014) noted that the 
interview setting is vital to the quality of the research, whereas Yin (2014) emphasized 




An informed consent form is a regulatory requirement for participants to confirm 
their willingness to participate in a study after they know all aspects of the study that are 
relevant (Rubinstein, Karp, Lockhart, Grady, & Groft, 2014). I obtained Walden 
University (IRB) approval with the approval number 11-10-17-0371674 to conduct the 
study. Upon Walden University (IRB) approval, I sent an informed consent form to each 
participant to review after accepting the invitation (Appendix B) to participate in the 
study. Participants who chose to participate in the study signed the consent form and 
returned it to me. Participants can withdraw from a study at any time without giving any 
reasons (Rubinstein et al., 2014). Participants had the opportunity to withdraw from the 
study, by contacting me via phone or email to express their desire to withdraw. I would 
have accepted the request and then delete all their information relating to the study.  
Participants participated freely in the study without any offer of incentives to 
avoid coercion and effect on the quality of the study. As such, I did not offer incentives 
for the study. Kennedy and Ouimet (2014) reported mixed outcomes on the use of 
incentives to increase participation rate in a study. Researchers need to understand the 
ethos of ethical standards and guidelines including avoidance of financial inducement in 
research (Polacsek, Boardman, & McCann, 2017). Ethics is an essential component of the 
research, that relates to the integrity of the researcher and others associated with the 
study. I earned a certificate entitled Protecting Human Research Participants (Appendix 
C) to assure that I understood the ethical protection of participants. Pisani et al. (2016) 
highlighted measures that researchers use to assure adequate protection of participants 
69 
 
including (a) adequate informed consent, (b) safeguarding data, and (c) minimizing 
intrusiveness and fatigue. I took steps to protect participants through data protection, 
maintaining confidentiality, adhering to IRB guidelines, respect for participants, and the 
use of informed consent. O'Keefe and Rubin (2015) noted that researchers are bound to 
keep the identity and confidentiality of research participants and must de-identify all 
information to avoid bias and to obtain an accurate analysis.  
I stored all my data in secure cloud storage and on an external hard drive kept in a 
secured/locked cabinet only accessible to me for 5 years. Researchers can destroy both 
physical and digital data after the 5-year period (Rubin & Rubin, 2012). I identified 
participants only by codes (e.g., P1, P2, P3, and P4 for participant 1, 2, 3, and 4 
respectively) to maintain confidentiality and use a study number with their documents. 
Researchers can identify participants using codes to hide the participant’s identity 
(O'Keefe & Rubin, 2015). I redacted all personal information on file, preserved the 
confidentiality of proprietary information from key participants in the company, and 
upheld ethical codes for researchers to protect participants’ privacy. 
Data Collection Instruments 
The researcher conducting the interview is the primary data collection instrument 
in a case study (Marshall & Rossman, 2016; Roy et al., 2015). As the primary researcher, 
I collected, recorded, and transcribed the data collected from the interviews. Case study 
researchers may use a variety of instruments for data collection, including questionnaires, 
interviews, focus groups, and observations (Baskarada, 2014). Conducting interviews 
using teleconference enables researchers to gain access to participants in different 
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locations, provide real-time interactions and opportunity to experience visual cues 
(Redlich-Amirav & Higginbottom, 2014). Teleconferencing provides a similar 
experience as face-to-face interviews, but good technology and attentive participants 
ensure effective meetings (Goodman-Deane, Mieczakowski, Patmore, & Clarkson, 
2015). Similarly, Redlich-Amirav and Higginbottom (2014) stated that teleconference is 
an appropriate interview setting because it provides simultaneous interaction between the 
researcher and participants. 
 Semi-structured interviews are flexible and afford the researcher a clearer 
understanding of the participant’s viewpoints (Wolfe, Gotzsche, & Bero, 2013). Case 
study researchers obtain secondary data from multiple sources of evidence (i.e. company 
documents, government publications, and routinely collected data) or a combination of 
those with the primary data collection instruments (Ketokivi & Choi, 2014; Tijjani, 
2014). I used archival records as the secondary data source to the case. The interview 
questions were concise so that respondents could easily understand the questions and 
respond. The interview form contained open-ended, in-depth interview questions that 
allowed for follow-up questions. I conducted interviews in person and via teleconference. 
I recorded the interviews digitally. Before data collection, I addressed ethical issues with 
participants using the informed consent form to assure each participant of their rights and 
confidentiality. I developed an interview protocol based on the framework adapted from 
Baskarada (2014) and Wolfe et al. (2013). I began the interview process by contacting the 
participants to schedule an appropriate time for a phone interview and sent the consent 
form. On the interview date after receiving the completed consent form and confirmation 
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of interview time, I introduced myself, provided a background of the study, reviewed the 
consent form, and obtained spoken consent to record the conversations. I informed the 
participants of the confidentiality of the interview to reassure them and to make them feel 
comfortable enough to offer their opinions and to provide truthful answers to probing 
questions. I started with open-ended questions and with follow-up questions as required. 
A phone interview process has the advantage of wide geographical access and offers the 
opportunity to gain access to research participants who might otherwise be difficult to 
reach (Ward, Gott, & Hoare, 2015).  
 To enhance the reliability and validity of data collection, I conducted transcript 
review and employed member checking. Qualitative researchers use member checking 
primarily for quality control to improve the accuracy, credibility, and validity of 
recordings of an interview (Birth, Scott, & Cavers, 2016; Morse, 2015). I collected 
secondary data from available literature including government reports, company reports, 
and publicly available data to triangulate the interview data. Multiple lines of evidence in 
the form of documentation, field notes, photos, excerpts from multimedia, archival 
records, and observations are essential components of a case study (Morgan et al. 2017; 
Yin, 2014). I reviewed company websites, publications, government agencies, social 
media, and related online resources to gather secondary data. Starman (2013) encouraged 
researchers to use multiple sources of data where appropriate to improve the outcome and 
validity of their research. Still using member checking, I augmented the data collection 




Data Collection Technique 
Researchers are the primary data collection instruments in the qualitative study 
and have multiple options for data collection, including interviews, observations, 
document reviews, and archives (Morgan et al., 2017). In case study, data collection 
involves following case study protocol using multiple sources of data (Yin, 2014). I used 
in-person and telephone interview format to collect data, archival documents from the 
company, government agencies and industry group. The researcher’s instrument for data 
collection is the semistructured interviews, which is a guided conversation and one of the 
primary sources of data in the case study (Baskarada, 2014).  
A semistructured interview is flexible and allows the researcher to have a better 
understanding of the participant (Yin, 2014). Interviews are critical data collection 
instruments in a case study, given that interviews are conversations used by researchers to 
obtain that information they cannot easily get using other instruments (Baskarada, 2014). 
Case study researchers use structured, semistructured, or unstructured interviews. Semi-
structured interviews are flexible and afford the researcher a clearer understanding of a 
participant’s viewpoint (Wolfe, Gotzsche, & Bero, 2013). An advantage of conducting 
interviews is the chance for researchers to develop a relationship with participants (Yin, 
2014). In addition, Baskarada (2014) noted that researchers use interviews for data 
collection to ensure the topic of research remains the focus of the study. I used 
semistructured interviews to explore strategies that managers in a pharmaceutical 
company used to ensure compliance with regulation.  
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Doody and Noonan (2013) and Yin (2014) articulated the advantages and 
disadvantages of using semistructured interviews in a study including: (a) participants 
may not stray away from the topic, (b) researchers can predefine the interview questions 
relative to the conceptual framework of the study, (c) possibility of using interview 
protocol allowing for interview confinement to the conceptual framework of the study, 
and (d) ability of researchers to explore all the areas required for the research. The key 
disadvantage of using semistructured interviews is the difficulty associated with 
processing data from it (Yin, 2014). Dasgupta (2015) noted that interviews are slow and 
present a concomitant challenge to connect and organize similar statements from 
different participants. Another drawback of this technique is that the researchers must ask 
questions carefully (Yin, 2014) and appraise what and how to present the questions in the 
right context (Baxter & Jack, 2008), which may result in investigator bias (Baskarada, 
2014). 
In conducting semistructured interviews, six key elements are required: (a) 
selecting the type of interview, (b) establishing ethical guidelines, (c) crafting the 
interview protocol, (d) conducting and recording the interview, (e) crafting the interview 
protocol, and (f) reporting the findings (O’Keeffe et al., 2016). I provided a detailed 
description of the data collection technique in Appendix A. Upon receiving IRB 
approval, the interview process began by contacting the chosen company contact person 
to obtain the contact information of potential participants in the study. After receiving the 
list of potential participants, I contacted them via email using the content in Appendix B. 
The letter contained a description of the study and an explanation of the requirements and 
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their rights, risks, and benefits. I avoided conflict of interest in all ramification in 
participants’ selection process. I stuck to the interview protocol that I designed for this 
study to ensure consistency in my approach to each participant. 
Researchers may enhance the validity of their study using multiple data sources 
including documents, archival records, direct observations, and physical artifacts (Yin, 
2014). The key disadvantage of reviewing documents is that they may not accurately 
reflect the facts, for example, some of the documents may contain obsolete information 
(Baskarada, 2014).  However, secondary data are easier to collect, save time and money 
(Marshall & Rossman, 2016). The second data source may provide additional 
information about the topic not captured through the primary data source. I obtained 
additional information from company reports and publications that are publicly available. 
Researchers employ member checking to ensure an accurate reflection of 
participants’ views (Cope, 2014). With member checking, participants contribute to the 
narratives of the findings before the publishing of the study (Noble & Smith, 2015). 
Through member checking, I enhanced the confirmability of every aspect of this study. I 
regularly checked participant’s understandings of each question and paraphrase and 
summarize their responses to each question for clarification. Interview technique requires 
the researcher to listen attentively for any new or interesting data the participant provides 




Data Organization Technique 
Researchers often organize the data into electronic file systems readily available 
and accessible for analysis (Gale, Heath, Cameron, Rashid, & Redwood, 2013). The next 
process after data collection is entering the interview transcripts into a storage system 
using the right tools (Bernauer, Lichtman, Jacobs, & Robinson, 2013). I took notes and 
recorded responses from interview participants using a digital audio recording device 
connected to cloud storage for time and cost effective secure data management. Working 
with digital systems shortens the time required for transcribing and analyzing data (Yin, 
2014).  
I organized each participant’s audio-recorded responses, secured the raw data, and 
transcribed data in a location mostly accessible by me. I organized the data by keeping 
track of signed (a) consent form, (b) invitation emails, (c) transcripts, (d) recordings, (e) 
labeling systems, (f) company documentation, and (g) research journals. Yin (2014) and 
Stake (2013) acknowledged the relevance of methodically organizing research data. I 
stored all the research data in secure cloud storage and on an external hard drive kept in a 
secure/locked cabinet accessible only to me for a minimum of 5 years. I transcribed the 
interview recordings using MS Word document and then stored them in the same way. 
Data Analysis 
Triangulation is a critical component to strengthening research validity (Yin, 
2013). Qualitative researchers assess and validate their research using triangulation 
(Johnson et al., 2017). Triangulation allows for analyzing the research problems from 
different perspectives (Johnson et al. 2017; Turner, Cardinal, & Burton, 2017). 
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Triangulation involves the use of multiple sources to study a case, minimizing the 
weaknesses of research design and enhanced understanding of the case (Turner et al. 
2017). Baskarada (2014) identified four types of triangulation: (a) methodological 
triangulation, (b) data source triangulation, (c) investigator triangulation, and (d) theory 
triangulation. Methodological triangulation involves using more than one method for data 
gathering in the study of a phenomenon, which is beneficial in confirming research 
findings (Turner et al. 2017). Case study findings are more convincing and likely to be 
more accurate with methodological triangulation (Yin, 2014).  
I used methodological triangulation to analyze the evidence from multiple data 
sources to identify themes that aided in the assessment, interpretation, and deduction 
from the information generated. Researchers find themes based on the responses to the 
interview questions. I used content analysis to analyze documents obtained from the 
study organization for triangulation. The content analysis consists of preparation, 
organization, and reporting and counts themes or codes, and can help to identify the most 
common topics (Baskarada, 2014). The components of data analysis include three 
activities: (a) data reduction, condensing data into themes; (b) data display, which is the 
organization of information to allow for deductions; and (c) arriving at conclusions and 
verification (Tijjani, 2014). 
I used a computer-assisted qualitative data analysis tool called NVivo and 
Microsoft Excel to code, identify patterns and themes, and analyze study data. The next 
phase was transcribing the recorded interviews and emailing the transcripts to each 
participant to confirm that the content of the analysis corresponded to the views 
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expressed. Researcher studies the outputs from this software to establish any emerging 
patterns, insights, and concepts. I: (a) read in detail each transcription to understand the 
contents, (b) read each transcript over again to extract key themes and sentences relevant 
to the case study, (c) attributed meaning to each significant affirmation, (d) placed each 
meaning into group of themes, (e) supplemented the results with detailed description of 
case, (f) described the key structure of the case, and (g) validated the data. Sotiriadou, 
Brouwers, and Le (2014) presented guidance for conducting qualitative data analysis 
using an NVivo software program and screenshots of the data analysis process. I 
analyzed the study data using the framework method for the management and analysis of 
qualitative data.  
The framework method is a type of thematic analysis or qualitative content 
analysis that defines the matrix output: rows (cases), columns (codes), and cells of 
abridged data, giving structure to which the researcher can methodically reduce the data 
so as to analyze it by case and by code (Ritchie et al., 2014). Researchers using thematic 
processes identify similarities and differences in qualitative data before concentrating on 
connections between various parts of the data, to arrive at descriptive and explanatory 
conclusions clustered around themes (Gale et al., 2013). Framework method is a flexible 
tool that a researcher can customize for use with many qualitative approaches with the 
objective of generating themes. The procedure for framework method of analysis occurs 
in seven stages: (a) transcription, (b) familiarization with the interview, (c) coding, (d) 
developing a working analytical framework, (e) applying the analytical framework, (f) 
charting data into the framework matrix, and (g) interpreting the data (Gale et al., 2013). 
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Researchers may develop themes using a database, which allows them to develop 
audit trails from data gathering, through analysis, and to the final deductions (Baskarada, 
2014). The analysis of findings of a study using previous reports or studies and 
conceptual framework provide authors with the ideas for articulating themes and 
structures (Yin, 2014) for their research. I extracted themes from each unit of analysis 
using a conceptual framework selected as the guide theory for this study and information 
from published studies. Researchers identify gaps in previous research by extending 
existing theory while using a conceptual framework to guide the study (Marshall & 
Rossman, 2016). 
Reliability and Validity 
Evaluating the quality of a study is essential for practical utilization of the results 
and drawing useful conclusions (Noble & Smith, 2016), and the quality of any empirical 
study including case studies is dependent on construct validity and reliability (Yin, 2013). 
What follows is a description of the strategies to enhance the study reliability and 
validity. 
Reliability 
The concept of dependability relates to the accuracy, repeatability, and 
dependability of a qualitative study just as ensuring reliability in a quantitative study 
(Yin, 2013). Houghton, Casey, Shaw, and Murphy (2013) posited that researchers ensure 
dependability and assure high rigor and robustness of the research process and results by 
diligently recording the research methodology and decision-making. Researchers may 
improve dependability in the study by using member checking (Elo et al., 2014). I 
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allowed participants to check the accuracy of the interpretations of their interview 
responses by sharing the data interpretation with the participants to confirm that the 
interview data corresponded to the thoughts they expressed. I also ensured dependability 
by keeping reflective notes and memos through the interview process and data analysis. 
Morse (2015) asserted that member checking enhances dependability by improving the 
accuracy, credibility, and validity of data during interviews. Member checking also 
allows researchers to improve the quality of their study through validation of transcribed 
information with study participants (Birt, Scott, Cavers, Campbell, & Walter, 2016). 
Validity 
Validity is the extent of compliance with the interpretation of the event and the 
realities of the world (Houghton et al., 2013). Also, Houghton et al. (2013) noted that an 
account is valid if it accurately portrays the features of a phenomenon that it describes. A 
qualitative researcher measures the validity of their research by evaluating the credibility, 
transferability, confirmability and data saturation of the study. 
Credibility in a qualitative study is the trustworthiness of the findings of the study 
(Noble & Smith, 2015). Researchers enhance the credibility of qualitative research 
findings through an accurate reflection of participants’ views by using member checking 
(Cope, 2014). Likewise, Houghton et al. (2013) suggested that in a qualitative study, 
researchers could enhance credibility if participants can verify the descriptions the 
researcher presents. Qualitative researchers may assess and validate their studies using 
member checking by allowing the participants to review the interview interpretations 
(Wilson, Onwuegbuzie, & Manning, 2016). Using member checking, researchers can 
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highlight problems by examining data and address any problem to maintain the integrity 
of the research findings and strengthen the outcome of the study (Lishner, 2015). I 
allowed members to check their interview responses using the interview transcript data to 
confirm that the interview data correspond to the thoughts they expressed to enhance the 
credibility of the study and to reduce research bias. 
Transferability is the extent to which researchers can apply the findings of a study 
to similar settings or groups (Cope, 2014). Furthermore, Elo et al. (2014) described 
transferability as the potential for readers of the study to transfer the research findings of 
the study to another given the detailed description of the critical aspects of the study. Key 
components of the research study including research method, description of participants, 
and steps taken during analysis (Cronin, 2014; Elo et al., 2014). Researchers use 
interview protocols to maintain data consistency (Baskarada, 2014). I ensured 
transferability by providing a rich description of the interview process in the interview 
protocols and adhering to the scripts in the interview protocols. 
Confirmability refers to accuracy, neutrality of study data, and the process of 
comparing data collected from multiple sources (Houghton et al., 2013). Morse (2015) 
argued that confirmability is the extent to which other researchers corroborate the 
outcome of a study to ascertain that the results are true representations of the participants’ 
responses and devoid of researcher bias. I ensured confirmability by leaving an audit trail 
that will readily be retrievable to allow for later inspection by other researchers. This will 
allow other researchers to check the pathway of decisions I made in the data analysis. The 
audit trail will include the list of questions, actual reports, notes, memos, study protocol, 
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transcribed text, bibliography, and related databases. Cronin (2014) suggested that 
researchers using multiple data sources overcome bias associated with a single data 
source thereby increasing confidence in the result and confirmability of the study. 
Data saturation refers to the state where there is enough data to replicate a study 
(Fusch & Ness, 2015). Bernard (2013) noted that evidence of data saturation occurs when 
the researcher cannot obtain additional information and lack further coding. Malterud et 
al. (2015) argued that researchers attain data saturation by asking multiple participants 
the same questions in a uniform manner. I interviewed many participants to ensure data 
saturation until I reached the point where no new information is emerging from the data. 
Transition and Summary 
Section 2 includes a discussion of the research methods and design, detailing the 
use of a qualitative case study technique. The key elements of this section include my 
role as the researcher and the criteria for selecting participants for this study. I identify 
the study population and the choice of the purposive sampling method. The section also 
contains information about how the researcher ensured high ethical standards and used 
in-depth interviews as the data collection instrument. I also explain the method for data 
analysis and support statements with relevant scholarly peer-reviewed sources. In 
addition, I discuss the approach to mitigate bias while addressing the reliability and 
validity of the study. Section 3 includes a presentation of findings and applications of 
study findings to professional practice, including an analysis and discussion of the results. 
The section will also include the implications for social change, suggestions for action, 
and recommendations for further research.  
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Section 3: Application to Professional Practice and Implications for Change 
In this section, I present the findings gathered from an in-depth exploration of the 
strategies used by pharmaceutical company managers to ensure compliance with 
government regulations. The findings comprise a description of participants’ responses to 
semistructured interviews, document review, emergent themes, and correlation to the 
conceptual framework. In addition, Section 3 includes the application to professional 
practice, implications for social change, and recommendations for action. I conclude the 
study with the recommendation for further research, my reflections on the doctoral study 
journey, and conclusion. 
Introduction 
The purpose of this qualitative single case study was to explore strategies that 
managers in a pharmaceutical company use to ensure compliance with regulatory 
requirements. The overarching research question of this study was: What strategies do 
pharmaceutical company managers use to ensure compliance with regulatory 
requirements? I conducted in-depth interviews with four managers involved in regulatory 
issues in a company based in Nigeria to gain insight into the strategies managers use to 
ensure regulatory compliance. Fusch and Ness (2015) noted that researchers reach data 
saturation when no additional information emerges from subsequent interviews. I reached 
data saturation after interviewing the fourth participant. 
To obtain additional information and to enhance the validity of my study, I 
triangulated the interview data with secondary data that I collected from the company, 
including: (a) internal corporate documents, (b) annual reports, and (c) company website 
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materials. I also reviewed publicly available documents with information about 
pharmaceutical regulations and guidelines in Nigeria that included (a) regulatory 
agencies’ websites, (b) regulatory guidelines documents, and (c) newsletters to 
triangulate the study data. After receiving the IRB approval, before the interview began, 
each participant reviewed and signed an informed consent form. I conducted the 
interviews at the research establishment and via teleconference with each interview 
session lasting between 35 minutes to 45 minutes. Upon the completion of the interviews, 
I transcribed the recorded interviews and assigned codes to all participants. Each 
participant was assigned a code to protect their identity and maintain the confidentiality 
of the participants. The assignment of codes to protect participants aligned with the 
observation of O'Keefe and Rubin (2015), that researchers could identify participants 
using codes to redact the participant’s identity. I assigned participants numbers from 1 
through 4 with P1, P2, P3, and P4 for participants 1 through 4 respectively. 
Presentation of the Findings 
The overarching research question of this study was: What strategies do 
pharmaceutical company managers use to ensure compliance with regulatory 
requirements? I used semistructured interviews with eight probing questions and follow-
up questions to allow participants to provide in-depth information about their experiences 
in regulatory compliance. I transcribed the interview audio recordings and was careful to 
ensure that interview transcripts reflected the contents of the audio recording. De Massis 
and Kotlar (2014) noted that researchers enhance the accuracy of interviewee transcripts 
by reading transcripts while listening to the interview recordings. After the transcription, 
84 
 
I followed up with transcript review for participants to validate the accuracy of the 
interview responses of their interviews. Some of the participants shared SOPs, employee 
training information, regulatory inspection sheet, annual reports, and general guidelines 
from authorities.  
I used Microsoft Excel and NVivo 11 Pro for Window software to analyze data 
and to identify frequent themes and word patterns that participants provided during the 
interviews. The data from this study resulted in the emergence of three themes:  
 Establishment of regulatory affairs unit and engaged leadership enhanced 
compliance 
 Qualified employees and learning enhanced compliance with regulatory 
requirements 
 Strategies to navigate through barriers to enhance regulatory compliance 
Theme 1: Establishment of Regulatory Affairs Unit and Engaged Leadership 
Enhanced Compliance 
The first theme to emerge from data analysis was that the establishment of a 
regulatory affairs unit and enabling leadership enhanced compliance with regulatory 
requirements in the company. All participants maintained that the establishment of a 
regulatory affairs unit in the company facilitated the coordination of regulatory activities. 
Each of the participants also emphasized the importance of engaged leadership and how 
engaged leaders have undoubtedly influenced the company managers’ compliance with 
regulatory requirements. Two subthemes emerged from the main theme: (a) regulatory 
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affairs unit, and (b) engaged leadership. All the participants indicated that the two items 
contributed to the enhanced functioning of the regulatory affairs department. 
Regulatory affairs unit. Analysis of interview data revealed that all participants 
(P1, P2, P3, and P4) considered the creation of the regulatory affairs unit as an effective 
strategy to enhance regulatory compliance. In particular, establishing the regulatory 
affairs unit played a critical role in enhancing managers’ ability to ensure compliance 
with regulatory requirements. Because of the establishment of the regulatory affairs unit, 
managers and employees were more attuned to compliance with regulations (P1) and 
facilitated the building and maintenance of good relationships with various regulatory 
agencies (P3). Having a regulatory affairs team responsible for communicating and 
implementing regulatory requirements that govern the pharmaceutical industry within the 
company has helped to increase employees’ compliance with regulation and minimize 
regulators citation. The managers’ position on the establishment of a regulatory affairs 
unit strengthened Tanwar, MittalI, Gugnani, and Sharma (2015) assertion that regulatory 
affairs unit in the pharmaceuticals industry perform key function given the rise and need 
to respond to regulation in a competitive business environment. The regulatory affairs 
unit team members work on regulated projects and activities in the company to ensure 
compliance with various regulations that affect the pharmaceutical industry.  
A key function of the regulatory affairs unit, according to P1 and P3, is the 
lobbying of critical stakeholders to ensure total regulatory compliance by the company. 
Effective lobbying of stakeholders may secure waivers and shorten the time required for 
the regulatory authorities to process documents, grant permits, and approve 
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pharmaceutical product distribution (Papaioannou, Watkins, Mugwagwa, & Kale, 2016). 
Regulatory affairs unit has a proactive plan on the ways to respond and implement 
changes to regulatory guidelines and regulations to ensure compliance with the changes 
in legislation (P1). Tanwar et al. (2015) reinforced the importance of having a regulatory 
affairs department to provide strategic and operational skills required to address 
regulatory requirements for the growth, safety, and effectiveness of pharmaceutical 
products to consumers. The unit interprets and disseminates regulatory guidelines across 
departments and to vendors, particularly those affected by regulatory guidelines and 
updates for their input, adjustments, and lobbying. 
All participants (P1, P2, P3, and P4) agreed that one of the ways the regulatory 
affairs unit team performed their role was through the gathering of knowledge on 
pharmaceutical legislation and a consistent effort to scout for new knowledge on 
legislation. Having an adept and knowledgeable individual as the regulatory affairs unit 
manager to lead the regulatory compliance efforts of the company is crucial to the overall 
regulatory compliance strategy of the company (P3). P2 and P3 substantiated the claim, 
noting that, for the unit to function optimally, a qualified pharmacist with experience in 
regulatory and quality duties should head the department, liaises directly with regulatory 
agencies, and coordinate regulatory activities within and outside of the organization. 
Having a knowledgeable manager positively influences the coordination of regulatory 
and quality tasks of the company, as well as providing effective supervision of employees 
in the unit (P3).  
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The team members of the unit maintain proper documentation and records to 
provide a picture of the company’s manufacturing, distribution, and marketing operations 
as a basis for planning to ensure compliances with regulation (P1). The finding that 
adequate record help ensure compliance with regulation aligns with the findings of 
Chaudhari, Yadav, Verma, and Singh (2014) who expressed that keeping adequate record 
and company documents was critical in compliance. The regulatory affairs team has a 
developed a system that allows for an efficient response to regulatory questions from 
regulatory agencies and other units of the company.  
All participants communicated that the regulatory affairs unit interfaces with 
regulatory agencies, and also coordinate their visits to the facilities. The principal 
agencies that the regulatory affairs unit interfaces with are (a) the National Agency for 
Food, Drug Administration, and Control (NAFDAC), (b) the Pharmacist Council of 
Nigeria (PCN), and (c) the Standard Organization of Nigeria (SON) and other statutory 
agencies that indirectly impact the operations of the company. Chaudhari (2018) 
explained that, in an era where regulatory agencies closely monitor every aspect of 
pharmaceutical supply chain and information shared with consumers, the establishment 
of a department that liaises with regulatory agencies and coordinate regulatory activities 
was critical. P2 and P3 reinforced Chaudhari’s assertion with their inference that the 
company seamlessly integrated the regulatory affairs unit into its strategic decisions. 
Inefficient interaction with regulatory agencies affects brand, sales, and market shares. 
Desai (2016a) posited that organizations establish close collaborative relationships with 
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regulatory agents to overcome uncertainty. Collaborations with regulatory agencies 
enhanced organizational compliance with regulatory requirements.  
P3 spoke about the involvement of the executive board in the supervision of the 
regulatory affairs unit to help resolve complicated regulatory challenges. One of the ways 
the unit resolved these challenges was to escalate serious regulatory compliance issues to 
the leadership level. The functional head of the regulatory affairs unit escalates problems 
through the superintendent pharmacist on the executive board of the company. The 
superintending pharmacist reports complex issues that require the input of the 
management board members to the executive board. The board is the ultimate decision-
making body of the company, charged with resolving all business matters not reserved 
for the general meeting of shareholders. 
Engaged leadership. All participants (P1, P2, P3, and P4) identified engaged 
leadership as a significant strategy that enhanced compliance with regulatory 
requirements. Specifically, the engagement of the executive board of the company in 
regulatory decisions facilitated regulatory compliance. According to P1 and P3, the active 
involvement of the senior leadership in regulatory issues was an indication of the 
relevance attached to compliance with government regulations and product safety. 
Executive board participation and support was consistent with Galuska (2014) who 
revealed that producing excellent outcomes requires influence leadership at each level of 
a complex system. The board regularly assesses the performance of the regulatory unit 
via unrestricted access to information to ensure satisfactory coordination business 
activities according to codes and laws by the company. 
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All participants believed that three behaviors of the leaders bolstered efforts to 
ensure compliance with regulatory requirements. One of the behaviors was the creation 
of regulatory vision with concrete goals and objectives, which ensured that managers and 
employees understood the significance of regulatory compliance. Second, the participants 
in the study also highlighted that fostering strict compliance, by consistently adapting to 
regulatory requirements, promoted a conducive business environment. The finding on the 
promotion of a conducive business environment echoed the assertion of Chhotray, 
Siverstsson, and Tell (2017), that a company vision should mirror a culture that bolsters 
employees’ daily activities and decisions. Third, the support of the executive board for 
regulatory compliance aided the overall compliance with regulatory requirements in the 
company. P3 believed that the leader's engagement with the decision-making on 
regulatory activities and resolving issues directly related to regulatory compliance, the 
regulatory compliance was obvious companywide. Blomme et al. (2015) noted that 
changes create the need for leaders to adapt for the organization to survive and the 
strategies deployed by managers to adapt are communication, active participation and 
influence techniques. In responding to regulatory developments, the leaders promptly 
adapt to changes and the dictates of those involved in regulatory activities. 
In summing up the importance of engaged leaders, P1 and P3 mentioned that the 
support of the executive board members was important in implementing the requirements 
in any specific area affected by any regulation. The focus of the company’s culture 
revolved around stakeholders’ interests, sustainability, overall support, and alignment of 
company strategic goals, and this influenced the support of leaders for compliance with 
90 
 
regulatory guidelines and laws. The leaders set in motion strategies that allowed for the 
development of key regulatory compliance tools including corrective action and 
preventive actions (CAPA), standard operating procedures (SOP), and other internal 
compliance documents. Employees used the documents as a guide in their daily tasks as a 
way of having a uniform compliance approach to regulatory requirements. P3 stated.  
The primary way we assess the measure of noncompliance or (CAPA) is when the 
regulatory bodies audit us for assessment, the measure of noncompliance that we 
receive is an indication of the effectiveness of our internal systems. We also have 
our routine quality audit in our processes that take place from time to time. We 
observe how many non-compliances are being reported and whether this 
noncompliance is major or minor. Let us not forget that it is also mandatory for 
regulatory authorities to always come in from time to time to audit our system. 
These two measures give us a feedback.     
A review of the document Corporate Governance Practices (D1) obtained from 
the company indicated that the executive board was involved in governance and ensuring 
that departmental leaders implemented strategies and programs that were supportive of 
regulatory compliance. D1 was a corporate governance document that served as an 
operating guide for compliance with codes, including best practices and ethical standards 
in all aspects of the company’s operations. The document had information on the 
governance structure, responsibility of the leadership of the company, and maintaining 
amicable relationships with various stakeholders. 
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The information obtained from D1 corroborated the assertion of P1 and P2 about 
the involvement of the leaders and facilitating compliance with regulation in the 
company. An excerpt from D1 corporate governance document on the role of the 
executive board states, 
The company continued to subject its operations to routine audit by independent 
auditors that include the current Good Manufacturing Practice (cGMP) and the 
National Agency for Food and Drugs Administration and Control (NAFDAC). A 
committee led by an executive director review the report for appropriate 
implementation of the recommendations. 
Krause, Semadeni, and Cannella (2013) asserted that board members commonly 
influence organizations and accomplish this through any of three primary processes: (a) 
offering advice to management, (b) procuring resources for the organization, and (c) 
monitoring management having in mind the interests of internal and external 
stakeholders. As detailed in D1, the executive management committees drive the daily 
affairs of the company headed by an executive director who reports to the board of 
directors. The contents of D1 reinforced all participants’ assertion that the executive 
board was active in ensuring the accuracy, adequacy and timely rendition of the statutory 
returns and reporting to regulatory authorities. 
As constituted, the management structure serves to ensure that a standard 
procedure for reporting any form of noncompliance by employees or any strategic 
business associates is in place to ensure the sanity of their operations and enhance their 
reliance on key operational supports. The company leaders considered this important to 
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ensure overall sustainability of the company. D1 further revealed that the leaders 
predicated their engagement in management and influencing activities on various 
government code of corporate governance, compliance requirements, various statutory 
rules, and good manufacturing practice. The influencing activities mirror the submission 
by Desai (2016b) that the board of directors’ influence activities in an organization.  
Correlation to the conceptual framework. The findings of Theme 1 relate to 
CLT. CLT was advanced by Uhl-Bien et al. (2007) and the key constructs of complexity 
leadership theory are (a) administrative leadership based on strict control and 
bureaucratic hierarchy, (b) adaptive leadership based on creative problem solving, 
generating new conditions, and learning, and (c) action-centered leadership that involves 
immediate decision-making mechanisms used in crises and dynamic productivity. 
Specifically, the finding on the establishment of a regulatory affairs unit in enhancing 
regulatory compliance relates to adaptive and administrative leadership. All of the 
managers noted that the establishment of a regulatory affairs unit facilitated adaptability 
to regulatory requirements because the regulatory affairs unit interfaces with regulatory 
agencies, and also coordinate regulatory activities within the company. Baltaci and 
Balci’s (2017) highlighted the importance of activities coordination in organizations 
leading to adaptability to new conditions. The administrative leadership component of 
CLT to provides leaders with requisite skills to manage uncertainty rather than over-
control of every aspect of the business (Waldman & Bowen, 2016). The unit facilitates 
the administrative activities of the company including coordination and planning of 
regulatory compliance tasks.  
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Theme 2: Hiring Qualified Employees, Training and Continuous Learning 
Enhanced Compliance with Regulatory Requirements 
The second theme that emerged from data analysis was hiring qualified 
employees, training, and continuous learning enhanced compliance with regulatory 
requirements. All participants (P1, P2, P3, and P4) shared that the hiring of qualified 
individuals for the right jobs was critical to the overall regulatory compliance strategy. 
The hiring of qualified individuals stemmed from a comprehensive compliance strategy 
based on a well-structured hiring and selection program. Training and continuous 
learning instituted in the company improved the organization’s compliance with 
regulatory requirements (P2). In addition, training created opportunities for employees to 
remain current and understand requirement in a dynamic regulatory environment. 
Recruiting qualified personnel has an impact on the ability of the workforce to be trained 
because regularly trained personnel had a positive impact in maintaining regulatory 
compliance in every operation companywide. 
Hiring qualified employees. All four participants shared that the hiring of 
qualified employees was an essential component of their strategy on compliance with 
regulations. P4 explained that to ensure regulatory compliance the company must have 
the right people for the tasks. A comprehensive recruitment strategy involved an 
established hiring process for all positions in the company. Developing an adequate 
recruitment strategy that conformed to the company priorities, skills, and training were 
determining factors credited for the company’s prominent level of success with 
regulatory compliance. P2 and P4 shared that employees who are lacking an adequate 
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background in related jobs, particularly in regulatory issues, undergo basic training on 
compliance to understand the pharmaceutical regulatory environment.  
The approach to recruiting qualified employees involved generating an accurate 
job description touting the skill sets and personality attributes required for completing 
tasks and fitting in with the culture of the company. In addition, P2 and P4 indicated that 
the company recruitment team uses online recruitment techniques to evaluate key 
behavioral traits and the cognitive reasoning ability of the job candidates. The online 
recruitment techniques generated information that helped to narrow the field of 
candidates to those with a high possibility of fitting into the company’s global 
compliance vision. Integrating this online recruitment method has the added advantage 
that the contemporary practice of employee screening through online platform influence 
recruiting decisions. The finding that online recruitment helped generate information 
about applicants that allowed recruiters make better decision aligned with the results of 
Melanthiou, Pavlou, and Constantinou’s (2015). Melanthiou et al. (2015) found that a 
well-outlined system and strategic application of available information about applicants 
significantly aid the recruitment of personnel with the required skills and competencies. 
Using different approaches to identify the most suitable candidate for the company has a 
critical impact on the ability of the workforce to perform the required task. In discussing 
the recruitment of personnel in the company, P3 said,  
We have a robust system in place where we strive to recruit people with a 
minimum educational background from reputable institutions done through our 
human resources department. We do not compromise with the recruitment of 
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people with the right qualification to fill openings. We extend our search for the 
right candidate by using various mediums to reach out to the right application for 
any position in the company. 
The highly regulated and knowledge-based pharmaceutical industry requires 
qualified personnel to operate in the complicated technical and high-demanding 
regulatory environment to be successful (P3). My findings about the recruitment of 
qualified employees are similar to those of Mehralian et al. (2014) who found that 
intellectual capital and intangible assets are critical tools in for the success of business 
entities in a knowledge-driven business environment. Likewise, Oseghale, Mulyata, and 
Debrah (2018) found that having intellectual capital was crucial for the success of the 
company, especially in the sub-Saharan African regions where a shortage of the right 
workforce is rife. P2 believed employees’ experience was a contributing factor to their 
successful compliance strategy and the company compensates for the experience by 
recruiting individuals with relevant qualifications and then setting them on a training 
plan. P4 explained that the company regards human-related challenges as critical, and one 
of the ways they overcome the challenge is through the recruitment of qualified 
employees who subsequently undergo training and a continuous improvement path. P4 
continued the explanation by saying “this is the way we overcome personnel-related 
challenges because if you do not have qualified personnel, you cannot trust the employee 
to perform their tasks.” 
All participants shared that, once recruited for the job, the company used training 
as a retaining strategy designed to ensure compliance with regulations. Although turnover 
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in organizations is not uncommon, retaining the right applicant is fundamental to avoid 
costs and diminished productivity. The company has a recognized human resources 
policy designed to create a work environment and that encourages the retention of 
employees (P3). Furthermore, P3 shared that the adoption of generous welfare packages, 
technical support, and continuous learning in the company led to the retention of 
employees. This finding on the adoption of a welfare package to retain employees was 
reinforced by Won, Wan, and Gao’s (2017). Won et al. (2017) asserted that employees 
who had a comfortable corporate culture, satisfactory emotional and technical support, 
work autonomy, and personal development programs were motivated to stay in their 
position.  
Msisiri and Juma (2017) found that effective employee retention depends on the 
continuous improvement of employees, the working environment, employee work-life 
balance, and the recognition and appreciation of employees. Haider et al. (2015) stated 
that adequate retention strategies were critical to retaining qualified employees. The study 
organization considered the retention of employees, particularly the technical staff, as an 
important task. Company leaders need to foster conditions that motivate employees to 
remain in the organization. 
Training and continuous learning. P1, P2, P3, and P4 reported that the 
employees training and continuous learning of employees had a positive impact on 
compliance with regulatory requirements. All participants observed that company leaders 
instituted policies that foster knowledge acquisition by employees. Training was a key 
strategy used to ensure regulatory compliance (P3). P3 added that the company policy of 
97 
 
investing in capacity building and workforce development is to equip and retool 
employees in the performance of their jobs. Specifically, the company has an established 
training and learning process that enabled employees to gain access to adequate training 
and to develop their ability to accomplish desired regulatory requirements. All employees 
receive training related to their job function and responsibilities. In addition, employees 
receive general compliance training on the company’s compliance program and code as 
well as policies and procedures (P2 and P4). Training facilitates employees’ ability to 
perform their tasks in accordance with their job description. Training and continuous 
learning promote participative culture, interest in knowledge-sharing and internal 
capacity development.  
According to P1 and P3, the company has a dedicated department charged with 
fostering the development of its workforce. Establishing training departments helps the 
company to realize its development goal of improving employee knowledge and skills 
that are beneficial to the organization. Employees receive training in different areas with 
an emphasis on their identified areas of weakness and deficiencies. The company 
conducted training in-house and those that needed further training went for external 
training both within Nigeria and outside of the country. The company’s focus was to have 
employees performing daily operational activities undergo regular training in compliance 
with regulatory requirements. These findings align with those of Kroll and Moynihan 
(2015) who found that training plays critical roles in closing specific capacity gaps and 
facilitates the implementation of new guidelines by providing information about the 
guidelines, rationalizing the reasons for the guidelines, and offering employees the 
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capacity to operate under new guidelines. Setting up a training department serves as the 
coordinating center for the development and growth of employees and the company as a 
whole.  
P3 shared that, 
We have in-house training and external training, both local and overseas, 
conferences, seminars, and others. It is a combination of both; there is a training 
routine, there is a full-fledged training unit in the organization. We have a 
learning and development unit that has the responsibilities to ensure that staff 
members are trained in the areas of their weaknesses and the area of their 
deficiencies. Both in-house and those that need to go for external training they go 
for external training both within Nigeria and outside of Nigeria. 
The executive board placed a premium on continuous learning in the company to 
keep all employees and third parties attuned to the overall strategic regulatory compliance 
goal of the company. Given the importance that company leaders associate with 
regulatory compliance, the leaders ensure that employees receive adequate training on 
compliance and knowledge acquisition to comply with regulations. The company 
regularly reviews the training policy to ensure it meets employee and regulatory 
requirements. The leaders’ disposition to adequate training is in agreement with the 
findings of Chhotray et al. (2017) who favored a leadership style that encourages the 
delegation of responsibility and empowerment of employees in a way that advances 
positive outcomes. Reflecting on training, Shin et al. (2017) stated that employees must 
develop new skills with the ability to handle new challenges. Because of the frequent 
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change in regulatory requirements, conforming to regulatory requirements demands that 
company leaders align training and development initiatives with strategic priorities 
particularly regulatory requirements.  
P3 added that the company policy of investing in capacity building and workforce 
development is to equip and retool employees in the performance of their jobs. 
Employees receive specialized training, and leaders identify the need for additional 
training for those working in regulation-related departments. Specialized training, such as 
regulatory learning incorporates an extensive regulatory training curriculum through a 
design that combines feedback from training, compliance, and sales representatives. This 
strategy reflects Nag and Das’s (2015) inference that an effective approach to training 
enhances an individual’s knowledge base. Similarly, Jayakumar and Sulthan (2014) 
suggested that effective training programs enhance productivity. P3 mentioned that one 
priority for the company was to invest in areas that required the closing of knowledge 
gaps through continuous learning. The company achieved continuous learning by 
allowing employees to undergo both in-house and external training both locally and 
abroad, in the form of conferences, seminars, symposia, and other related training. P2 
said,  
We train because we believe you need to be well informed as par what you need 
to do and also all these  are clearly stated in our standard operating procedures 
and before you can be placed on the job it is expected that you are trained 
properly with relevant SOPs to be sure that even as you do that you are being 
monitored, you are being evaluated, and to be sure that you will comply, not even 
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only to the various regulatory requirements and some operational details on the 
job. 
According to P2 and P4, the company employees embark on numerous types of 
training to understand regulatory requirements, company policies, and changes to guide 
their operational activities. P2 stated that the execution of any change begins with 
training on the use of internally developed company documents, such as the Standard 
Operating Procedures (SOPs). The SOPs serve as a training document and contains 
information about the training of employees on the job and continuous learning in the 
organization. The company regularly updates the SOPs to incorporate regulatory changes, 
and employees receive training on the SOPs on a quarterly basis to ensure that they 
understand current regulatory requirements. Particularly, continuous learning keeps 
employees refreshed to minimize the tendency for them to forget useful information (P2 
and P4). Employees appreciate the training received regarding the implementation of 
regulatory requirements.  
The introduction of new products and processes requires that employees receive 
adequate training with continuous learning programs about guidelines, required process 
training, post market surveillance, and product information (P1, P2, and P4). P2 gave an 
example of running a cold chain; employees in the chain undergo concise training in 
every aspect of the cold chain process with emphasis on regulatory requirements for 
effective control of storage condition, product quality, safety, and performance. While 
addressing the effectiveness of training and learning in the company, of P1 said, 
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We look at that time compared to what it used to be before, maybe for past 4 or 5 
months; I have not had any issue because it shows that the training is working. 
Maybe when we start seeing issues coming up. It also let us know people are 
losing focus, on this, which also take them back again for training, for us training 
is a continuous thing we do. 
The company conducts auditing and monitoring activities designed to assess the 
effectiveness of training and compliance with regulations by measuring the levels of 
variations recorded (P2). An increase in deviations is an indication that employees 
involved in the specific area are losing focus suggesting that such employees should 
undergo further training, lending credence to the assertion that learning is continuous. 
Another way to evaluate the impact of training on compliance was the use of key 
performance index (KPI) to assess compliance and to implement actions leading to 
minimal or elimination of noncompliance. 
For further analysis, enhanced understanding, and increased study validity, I also 
used secondary data in addition to the data obtained from interviewing participants. One 
secondary data source was an official release on the company’s website (D2) that 
described the company’s manpower development strategy. A review of the contents of 
D2 indicated that the company has a workforce and learning policy designed to equip 
employees with the required competencies and skills to perform effectively and 
efficiently on the job. The document revealed that the company training and development 
policy has two key objectives namely: (a) to drive a learning culture through strategic 
learning interventions that encourage employee growth and development and (b) to 
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improve employee productivity and personal effectiveness to achieve a sustainable 
competitive advantage. Stated in the D2 is that, “Various programs have been designed to 
realize the objectives which include, comprehensive staff orientation/induction program, 
internal and external training programs, departmental training, management roundtable 
conference, management retreats, seminars and workshops, job rotation, exchange 
programs with credible partners, etc.” This excerpt from the company’s webpage 
supported all of the participants’ affirmations that robust training and a continuous 
learning policy has a positive impact on regulatory compliance. 
A high-level overview of the company’s recruitment policy posted on the 
company website also provided the roadmap for the recruitment and retention of people 
with the right skills and expertise.  The website post on the company’s recruitment policy 
supported the assertion of P3 and P4 that the company has a robust recruitment process 
aimed at hiring the most suitable job candidate. The recruitment policy as posted on the 
company website reads, 
The company has recognized that an efficient hiring and candidate selection 
process contributes to the company’s success with unambiguous effect on the 
company’s ability attain its desired goal. The organization attempts to engage and 
hire individuals with the requisite skills, expertise, qualifications, and vision to 
deliver the company’s our objectives.” 
A review of the company 2015 Financial Statement (D3) revealed that the 
company has a strong retention incentive. D3 is one of the financial documents that 
outlines the financial activities of the company. The incentives serve as part of the 
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employee retention strategy of the company and include salaries, pension, and gratuity, 
among others. Within this document is the policy statement that “the company incentive 
schemes are designed to satisfy each employee needs that include (a) bonus, (b) 
promotions, (c) generous healthcare plan, (d) housing and (e) a pension plan in line with 
the provisions of the Pension Reform Act 2014.” The document also revealed that the 
company attaches high value to training and all categories of employees attend courses 
and seminars. These findings from D3 buttressed the assertion by P3 that one of the ways 
the company retains employees is by offering a generous welfare package and training. 
Good Manufacturing Practice Guidelines for Pharmaceutical Products (D4) is a 
document I obtained from NAFDAC that included the guideline on training requirements 
in pharmaceutical organizations. Stated in D4 is that “part of quality assurance which 
ensures that pharmaceutical products are consistently produced and controlled to the 
quality standards appropriate to their intended use and as required by their marketing 
authorizations.” The document reinforced the importance that the participants associated 
with training to ensure regulatory compliance. The guidance included in the document 
ensures the manufacturing of pharmaceutical products that are fit for their intended use, 
comply with the requirements of the marketing authorizations and do not place the 
populace at risk. D4 compelled manufacturers of pharmaceutical products to maintain 
sufficiently qualified personnel to perform all the tasks for which the manufacturer is 
responsible. 




 The manufacturer should provide training in accordance with a written 
program for all personnel whose duties take them into manufacturing areas or 
control laboratories (including the technical, maintenance and cleaning 
personnel) and for other personnel as required. 
 Besides basic training on the theory and practice of GMP, newly recruited 
personnel should receive training appropriate to the duties assigned to them. 
Continuing training should also be given, and its practical effectiveness 
periodically assessed. Approved training programs should be available. 
Training records should be kept. 
 Personnel working in areas where contamination is a hazard (e.g., clean areas 
or areas where highly active, toxic, infectious or sensitizing materials are 
handled) should be given specific training.  
 The concept of QA and all the measures, which aid its understanding and 
implementation, should be fully discussed during the training sessions.  
 Visitors or untrained personnel should preferably not be taken into the 
production and QC areas. If this is unavoidable, they should be given relevant 
information in advance (particularly about personal hygiene) and the 
prescribed protective clothing. They should be closely supervised. 
 Consultants and contract staff should be qualified for the services they 
provide. Evidence of this should be included in the training records. Records 
should be maintained stating the name, address, and qualifications of any 
consultants and the type of service they provide. 
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NAFDAC training requirements provided the foundation the company used to 
establish written policies and procedures for the hiring of qualified candidates and 
training of employees to ensure compliance with applicable laws and regulations. The 
policies and procedures apply to all employees and third parties. Adherence to these 
procedures is a condition of employment. The company expects all managers to ensure 
that their employees and third parties receive training on their specific duties, policies, 
and procedures, including all applicable laws, guidance, and regulations.  
Correlation to the conceptual framework. Theme 2 aligned with the conceptual 
framework of complexity leadership theory. According to complexity leadership theory, 
training and learning occur through interactions among agents and their functions (Uhl-
Bien et al. 2007). Baltaci and Balci (2017) identified skills, knowledge, and 
organizational learning as a critical component of CLT. Baltaci and Balci found that 
adaptive responses require learning for improved efficiency in an unstable environment. 
Specifically, in the context of this study, training and continuous learning facilitated 
employees’ ability to perform their tasks relative to their job descriptions. Company 
employees and leaders engaged in training and learning, which increased the level of 
regulatory compliance and presented a path for sustainability. Through the learning 
strategies used by the company, employees made sense of situations because learning 
occurred, and the knowledge created allowed the employees to adapt to regulatory 
requirements. Hence, training and continuous learning increased the company’s 
regulatory compliance through shared knowledge and understanding. 
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Theme 3: Strategies to Navigate through Barriers to Enhance Regulatory 
Compliance 
The third theme to emerge from data analysis was that having strategies to 
navigate through barriers to enhance regulatory compliance. All participants (P1, P2, P3, 
and P4) shared that barriers including (a) government barriers and (b) critical factors 
comprising finance, technical, infrastructure, and culture influenced managers to ensure 
compliance with regulatory requirements. Government barriers and critical factors 
influenced efforts to ensure compliance with regulatory requirements because of the 
burden that they placed on the company. Navigating through the barriers required 
strategies designed to help overcome each hurdle in the highly regulated pharmaceutical 
terrain. Overcoming these barriers required the company to adjust to regulatory and 
market realities while adapting to emerging issues for sustainable performance despite 
the barriers.  
Government barriers. An analysis of interview data suggested that overcoming 
government barriers had a critical impact on regulatory compliance (P1, P2, P3, and P4). 
According to P2, the company encountered obstacles in their quest to fulfill regulatory 
obligations. Frequent changes in government policies and a multiplicity of guidelines, 
codes, and laws were obstacles identified by P1, P2, and P3 as critical to the company’s 
ability to comply with regulations. The challenges the company encountered with 
government obstacles induced the leaders and managers to approach regulatory 
compliance in innovative ways by formulating strategies that were beneficial enough to 
outweigh the costs of those regulations for the company. Overcoming some of the 
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barriers require formulating a comprehensive approach that included the direct 
involvement of company leaders and representatives of the regulatory agencies.  
Regulatory officers’ own experience and biases affected conclusions on 
regulatory issues (P3). Dialogs with the assigned regulatory officer for a particular 
regulatory compliance project helped clear areas of concern to satisfy regulatory 
requirements. P1 cited an example where, upon the submission of an application to 
NAFDAC, officials of the agency insisted on facility inspection, despite having a valid 
GMP certificate valid for 2 years, in addition, the routine inspection conducted 
biannually. The double inspections led to complicated arrangements that greatly affected 
production as well as financial performance of the product because of delayed 
introduction of the product lines. P3 particularly expressed the displeasure of the 
company because of the complicated arrangements affect that overall business output of 
the company. Repeated inspection had an extensive impact on business operation and 
other activities in the facility because inspectors were not particularly concerned about 
the implication of timelines when they planned their site visits. P4 stated, 
Making an effort to comply with regulations sometimes helps but some 
government officials deliberately make things difficult. The regulatory agencies 
may disagree with what the company provided leading to delays and collateral 
impact on other activities about the manufacturing and other business operations.  
The company addressed such challenges through persistent dialogs with the 
regulatory officers assigned to the company. 
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With the experience of the company on regulatory matters, P1, P2, and P4 
asserted that the company always conducted a diligent review of (a) sample, (b) 
submission timeline, and (c) “compliance directives” issues, to prevent questions and 
deficiencies before approaching regulators for product registration, annual renewals, or 
facility inspection. Lack of adequate preparations, revisions of documents, and effective 
planning often resulted in delays of other activities because of logistical issues and 
potentially repeating the entire process. Adequate preparation before indicating to the 
authorities that the company had a product requiring registration was a key determinant 
of the successes achieved in regulatory compliance.  
All participants (P1, P2, P3, and P4) explained that multiplicity and duplication of 
government agencies roles and lack of definitive differences in the functions of some 
regulatory agencies was an obstacle to regulatory compliance. Participants’ assertion 
about the duplication of functions by government agencies and the general public-sector 
inefficiency buttressed Adanri’s (2016) observation that that public-sector incompetence 
was a contributory hindrance to business operations in Nigeria. P4 stated, 
Talking of government, the challenge is mainly related to the bureaucracy. One 
must move from one office to the other to have files processed, but recently we 
have noticed some changes because one of the agencies has introduced online 
submission of applications to overcome the burden of physically moving files 
from one table and office to another. This challenge with bureaucratic obstacle 
also involved having us traveling hours away from our location the main offices 
of the agencies. On reaching these government offices, we ended up waiting in 
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the office for hours certain activities that could be executed online. However, after 
persistent dialogs with regulators, we observed that some of the regulatory 
impediments were addressed by the regulatory authorities’ resulting in a lower 
rate of delays from regulatory authorities. As a result, many companies are 
complying, and particularly, companies like us that are always interested in 
compliance in every area of our processes both quality control, engineering, 
production, and documentation. 
 P1 and P4 attributed the proactive approach to regulatory issues that involve 
frequent interactions with key government agencies with direct impact on product 
imports, manufacturing, and distribution helped managers and employees to meet the 
expectations of each regulatory agency. The regulatory affairs unit respond to the issue of 
duplication by customizing their responses to each agency to meet their specific needs in 
the format required by the agency. The regulatory affairs unit liaises with each regulatory 
agency by identifying what the regulations are, which is foremost especially when 
dealing with the respective agencies (P2). Understanding the role of each regulatory 
agency in the pharmaceutical product value chain is essential to ensure that every product 
destined for distribution undergoes the required regulatory approval from product 
development through final consumption. The company maintained a checklist and 
additional follow up on the checklist generated for each regulatory agency with direct 
impact on the company business operations. Employing a system that leads to improving 
the compliance, built on a mutual working relationship between the organization and the 
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regulatory agencies, and helped mitigate the negative impact of the uncertainties in 
regulatory policies. 
Critical factors. P1, P2, P3, and P4 all expressed that critical factors influenced 
compliance with regulatory requirements. All participants indicated that critical factors 
included (a) culture of the people and their way of life, (b) finance, (c) infrastructural 
development, and (d) availability of resources. P2 and P3 particularly noted that business 
operations in Africa were challenging given the hurdles pharmaceuticals companies must 
contend with. P3 stressed that the cost of complying with standards was high because 
guidelines required that a number tests be conducted but the costs and availability of the 
materials made compliance almost impossible. P3 said, “The way that we conduct 
businesses in the African environment, where we do not have the types of resources 
available to companies in the West made regulatory compliance almost 
impossible.” Financial constraints on procuring equipment and materials increased the 
cost of compliance for products with the required quality standard, making these products 
expensive by Africa standards. Access to critical materials required for production is 
significant because local companies import most of the materials used in production 
thereby creating difficulty in product manufacturing chain.  
In addition, P1, P2, and P3 identified cultural constraints resulting from the 
mindset and attitude of the people. The people do not necessarily consider adherence to 
standards and compliance with regulations, guidelines, and code a priority. Using various 
campaigns to explain the importance of quality products that result from regulatory 
compliance influenced the noncompliance mindset of the people. Cultural influence 
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reinforced Bourke and Roper’s (2014) assertion that critical factors, including employees, 
organizational characteristics, and culture, influence decisions within an organization. 
Influencing the mindset of the general populace has an impact on overall compliance 
with regulatory requirements.   
All participants considered critical factors as extraneous barriers that company 
must work around by formulating strategies to enhance compliance with regulation. 
According to P3,  
If you have an infrastructural deficit, which is beyond your control, the company 
must provide alternatives. For instance, where you do not have electricity, you 
provide your generator, where you do not have low-interest rates loans; you must 
find other ways of bringing either equity for your business or raise debt.   
The company worked with business advocacy groups such as the Manufacturer 
Association of Nigeria (MAN) and the Pharmaceutical Manufacturer Association of 
Nigeria (PMAN). These advocacy groups engaged with the government and regulatory 
agencies in discussions to work on the constraints identified by business operators. The 
advocacy groups also mounted pressure on the government and society by organizing 
public discussions, press conferences, and press releases. Individual companies cannot 
assert the kind of influences that the advocacy groups bring to bear. The advocacy groups 
attempt to collaborate with similar organizations to shape or influence, agencies 
responsible for creating and enforcing mandates and to advocate for the provision of a 
conducive business environment. 
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NAFDAC and PCN (D5 and D6) are documents I obtained from statutory 
agencies that detailed the statutory responsibilities of the regulatory agencies indicating 
that different regulatory agencies have varied requirements. A review of D5 and D6 
revealed that each organization has a specific regulatory oversight function in the 
manufacture, distribution, and practice of pharmaceuticals in Nigeria. Regulatory 
agencies developed various guidelines for the registration and distribution of 
pharmaceutical products in Nigeria. D5 indicated that NAFDAC is the agency mandated 
to regulate and control the importation, exportation, manufacture, advertisement, 
distribution, sale, and use of pharmaceutical products in Nigeria. NAFDAC performs its 
functions by issuing guidelines on the requirements for registration of pharmaceutical 
products, including distribution, marketing, and storage of the products for safety and 
efficacy.  
D6 indicated that PCN functions in the issuance of establishment licenses to 
companies involved in the importation, manufacturing, and retail pharmacy. In addition, 
PCN is responsible for granting licenses for practicing pharmacy in the country. The 
pharmacist for each facility, company, pharmacy, or establishment must be the 
superintendent pharmacist who oversees the pharmaceutical organization. PCN grants 
license for establishments or pharmacists who will run or oversee the pharmaceutical 
processes that occur in that establishment and ensure that they are accountable for these 
pharmaceutical processes. 
Correlation to the conceptual framework. Theme 3 aligns with complexity 
leadership theory. In CLT, leadership is attained through the interaction of three 
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functions: (a) administrative, (b) adaptive, and (c) enabling Mendes et al. (2016). As it 
relates to this study, administrative function entails managerial activities of the company 
including coordination and planning of tasks. To navigate through barriers to ensure 
regulatory compliance, the company engaged in the formal planning of tasks such as a 
diligent review of (a) sample, (b) submission timeline, and (c) compliance directives 
issues. This allowed the company to prevent deficiencies before approaching regulators. 
The adaptive component of CLT related to this study emerged from complex interactions 
between the company, regulators, and other stakeholders with regard to conflicts, ideas, 
and preferences. Navigating through barriers requires adaptability in response to 
challenges and opportunities that enhance performance and innovation (Arena & Marion, 
2016). The interactions between agents, including government agencies, advocacy 
groups, and the company lead to adaptive change. In this study, the company, regulators, 
and advocacy groups engaged in interactive exchanges to solve challenges that they 
faced, which is an adaptive function. 
Applications to Professional Practice 
I conducted a qualitative single case study to explore the strategies used by 
pharmaceutical company managers to ensure compliance with regulatory requirements. 
Data obtained from interviews with four functional managers and company and public 
documents provided insight into the organization’s compliance with regulation in the 
pharmaceutical industry. Companies who comply with regulatory requirements have a 
higher chance of being successful (Rolling, 2017). Using strategies that encourage 
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regulatory compliance can eliminate or reduce unnecessary enforcement and compliance 
costs associated with legal actions between companies and regulatory agencies. 
Noncompliance with guidelines, codes, standards, and laws significantly affects 
organizations’ image and profitability (Mulinari, 2016). The findings in this study might 
provide managers and organization leaders with information relevant to the running of 
pharmaceutical businesses in a highly regulated business environment. Understanding 
what strategies led one organization to successful regulatory compliance could allow 
other organizations to identify and mitigate issues that may lead to noncompliance of 
their organizations as well. When organizations imperfectly comply with regulations, 
company operational costs increase because of the cost implications of fines and 
corrective actions. 
Another contribution to professional practice relates to the influence of senior 
leadership in ensuring compliance with regulatory requirements. This study findings 
revealed that leaders’ involvement and engagement in compliance strategies helped 
facilitate a compliance culture in the company. Increased engagement among senior 
leaders in ensuring regulatory compliance can lead to a solid reputation with regulators 
and customers, ultimately affecting company revenue and overall business performance.  
Implications for Social Change 
This study has implications for social change. The pharmaceutical companies play 
a significant role in driving social change in the community. The core of pharmaceutical 
business outputs is designed to improve and save people’s lives, which is consistent with 
the position of Konda et al. (2015) and Ney et al. (2015) that social change includes 
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generating good deeds critical to human welfare development and availability of 
pharmaceutical products. The availability of pharmaceutical products as a contribution to 
social change reinforces Muzaka’s (2013) position that the availability of pharmaceutical 
products was a social function that represents bargaining among government, business, 
and society. Availability of pharmaceutical products has implication on the overall health 
of communities. Compliance with regulatory requirements ensures that pharmaceutical 
companies develop high quality and safe products, which are critical in healthcare 
leading to the prevention, alleviation, and cure of diseases. Lack of access to quality 
medicine remains a vital issue in many communities, hence having strategies that lead to 
the development of pharmaceutical products through regulatory compliance will help 
combat drug shortage. 
Effective compliance regulatory strategies yield considerable social benefits, 
particularly in cost reduction. The inability of organizations to comply with regulatory 
requirements can be costly resulting in costs that companies transmit into the overall cost 
of the pharmaceutical products. Anyakora et al. (2017) noted that regulatory compliance 
can influence the availability, affordability, and plays an important role in cost reduction 
of pharmaceutical products. Niessen and Khan (2016) noted that having strategies to 
improve regulatory compliance might result in the pharmaceutical products that are 
affordable in most markets. Disruption of products supply may lead to societal ills, death, 
and public health hazard. 
116 
 
Recommendations for Action 
Pharmaceutical companies in Nigeria and sub-Saharan region of Africa can use 
the information in this study to develop strategies to ensure compliance with regulatory 
requirements. The findings signaled that pharmaceutical company managers might 
improve the level of regulatory compliance as a way to avoid the negative impact of 
noncompliance such as fines, company image, and reduced profitability. The strategies 
shared in this study might contribute to the success of company leaders and managers 
who lack the knowledge and strategies to ensure regulatory compliance. An increase in 
the level of regulatory compliance might result in increased productivity, profitability, 
and company success.  
The first recommendation is for pharmaceutical companies to establish a 
regulatory affairs unit with responsibility for handling all regulatory and compliance 
issues in the pharmaceutical product value chain. The regulatory affairs unit will serve as 
the coordinating center for the implementation of regulatory requirements. Tanwar et al. 
(2015) conducted a study on regulatory affairs unit in pharmaceutical companies and 
found that the regulatory affairs unit provided the strategic and operational skills required 
to address regulatory requirements effectively. Second, implementing a comprehensive 
recruitment strategy, which leads to the recruitment of only qualified employees to 
perform specific tasks. Mehralian et al. (2014) found that intellectual capital was critical 
to the success of the business organization. Third, I recommend that pharmaceutical 
company functional managers and leaders review the findings of this study on training 
and continuous learning because implementing a strategy that fosters knowledge acquired 
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through training and continuous learning facilitates employees’ ability to perform their 
tasks. Lastly, company leaders should formulate a comprehensive strategy that includes 
senior leadership member’s direct involvement with representatives of regulatory 
agencies.  
Researchers have many ways to disseminate their research findings including, (a) 
by presenting the findings as a policy brief to a non-specialized audience, (b) publication 
in a peer-reviewed journal, signaling the acceptance of the research within the 
community, and (c) writing a book from based on the research findings. I will 
disseminate the result of this study via scholarly journals, training, conference 
presentations, and developing the study into a book. I will provide a summary of the 
findings to the research establishment and specialized trade groups involved in both the 
pharmaceutical industry and in general regulatory compliance. I hope to disseminate my 
findings widely. 
Recommendations for Further Research 
This study was an exploratory study to understand the strategies used by 
managers to ensure regulatory compliance using complexity leadership theory as a 
theoretical guide. In this qualitative case study, I explored strategies used for compliance 
with regulatory requirements. In evaluating findings from the research, it is pertinent to 
note the limitations and context of this study while suggesting areas for future research. 
The first recommendation for further research is to extend the study to multiple 
pharmaceutical companies in the country to obtain results with wider reach given that this 
study was limited geographically to Nigeria and one organization. Yin (2014) noted that 
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with multiple cases, researchers have the possibility of direct replication, or might offer 
contrasting situations. In addition, the study was limited to functional managers, thereby 
limiting the number of participants; future research may increase the pool of participants 
to include senior leadership, employees, and nonsupervisory managers. I recommend 
increasing the pool of participants by conducting a multiple case study to investigate 
compliance strategies. 
The second recommendation is to perform a quantitative or mixed method study. 
Researchers use the quantitative method for data collection to test hypothesis or analyze 
data using statistical forms, and the results are generalizable (Brockington, 2014). 
Researchers can investigate relationships between financial indicators, and how the 
indicators influence regulatory compliance and to examine the impact of regulatory 
compliance on revenue or other financial indicators. The current study is an exploratory 
study providing only in-depth information about the lived experience. Conducting a 
quantitative study could generate results that might lead to the generalization findings. 
Future research in these areas might increase existing literature in regulatory compliance, 
especially among African countries.  
Reflections 
During the DBA study, I learned the importance of steadfastness and resolved to 
complete a task in the face of huge challenges from across the board. The program 
enhanced my confidence in the handling life-changing situations because the research 
phase of the program built my inner strength and tenacity to accomplish a goal. The 
challenges include issues relating to proposal development, finding the right research 
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establishment, and managing access to research participants. Within this period, I relied 
on networking to secure the research establishment and access to research participants; I 
fully appreciate the importance of networking to achieve desired goals. Owing to the 
nature of the topic and the location of the research establishment, it was a burden to gain 
access to the establishment and participants and use of networking made this study 
possible. 
Upon selecting the research establishment and research participants, I strived to 
minimize bias and personal errors right from the design of the research question and 
interview questions to obtain as much lived information from research participants. The 
in-depth review of the literature honed my skills in the development of the appropriate 
interview questions. In addition, I minimized bias by adhering to the interview protocol. 
Before this research study, my research was science-based; as such, I had no 
experience about research in management or conducting research interviews and was not 
involved in the interaction with the leadership of a corporate organization. The 
experience that I gained in this study provided me a new academic vista and prism due to 
the opportunity of interacting with professionals in the field and learning their lived 
experiences with the research topic. This study exposed me to successful business 
practices relative to regulatory compliance with the chosen location. Gaining insight into 
the strategies used for compliance offered me the opportunity to compare what I learned 
from the study with my experience about the topic in developed nations. I am now more 
attuned and have the requisite knowledge to discuss and contribute topics relating to 
regulatory compliance in the pharmaceutical industry in Nigeria, including their 
120 
 
regulatory framework, regulatory agencies, and stakeholders in the pharmaceutical 
industry in Nigeria. I will publish the findings of this study in the related or related 
professional and academic journals and publications as a contribution to the body of 
knowledge. 
Conclusion 
Ding et al. (2015) argued that compliance with regulation is critical to business 
performance, while Page et al. (2015) argued that noncompliance with regulation has 
become a challenge to managers. However, only a few studies exist on pharmaceutical 
companies’ compliance with regulatory requirements in the Sub-Saharan region 
(Olugbenga, 2013). Business Monitor International (2016) reported that Nigeria has a 
poor pharmaceutical regulatory environment; as such having insight into the strategies 
used by successful companies under such regulatory environment is an important 
contribution to knowledge and pharmaceutical business performance. Evaluation of 
business compliance under unstable business conditions such as the dynamic regulatory 
environment using complexity leadership theory is a plausible approach to understand 
how leaders adapt to the changes in the regulatory environment.  
The research question addressed the strategies that managers used to ensure 
compliance with regulatory requirements. Using CLT, I explored the strategies used by 
managers to ensure compliance with regulations. Based on participants’ responses and 
data analysis, I found that the establishment of a regulatory affairs unit and engaged 
leadership enhanced regulatory compliance. Similarly, the hiring of qualified employees 
and their compliance training learning improved compliance with regulatory 
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requirements. Furthermore, having strategies to navigate through barriers to enhance 
regulatory compliance. All participants emphasized the importance of compliance with 
regulatory requirements as part of the availability of products and business success. The 
results of this study underscore the critical importance effective regulatory compliance 
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Appendix A: Interview Protocol 
Interview Protocol 
What I will do script 
Introduce the interview and set the 
stage 
I am a student at Walden University pursuing 
my Doctor of Business Administration degree 
specializing in Technology Entrepreneurship. I 
am conducting a research study for my 
dissertation entitled “Strategies for Compliance 
with Government Regulations in a 
Pharmaceutical Company ". 
 The purpose of this qualitative single case 
study is to explore the strategies used by leaders 
in pharmaceutical companies to adapt to 
regulatory requirements. Management approval 
for data collection will be sought, and your 
participation in this study is entirely voluntary, 
you can withdraw from participating at any 
point of the data collection process.  
 
 Watch for non-verbal queues  
 Paraphrase as needed 
1. What is your role in ensuring 
compliance with government 
regulations in your company? 
157 
 
 Ask follow-up probing questions 
to get more in-depth  
2. What strategies do you use to 
prevent noncompliance with 
government regulations? 
3. How do you communicate 
regulatory requirements within your 
company? 
4. What specific strategies do you use 
to ensure regulatory compliance?  
5. What challenges do you encounter in 
implementing strategies for 
compliance with regulatory 
requirements?  
6. How do you address the challenges 
to the implementation of strategies 
for noncompliance to government 
regulations? 
7. How do you assess the effectiveness 
of your strategies to prevent 
noncompliance 
8. What other relevant information 
about compliance with regulatory 
requirements can you provide? 
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Wrap up interview thanking 
participant 
Thank you for your time and consideration, do 
you have any additional questions or 
comments? 
Inform participants about transcript 
review 
I would like to send you the transcript of this 
recorded interview; can you provide two dates 
and times you are available next week? 
 




1. I prepared verbatim transcripts of recorded 
interviews 
2. Verbatim transcript sent by email to each participant 
to review 





Appendix B: Invitation Letter 
Date: 
Re: Doctoral Research Study Invitation 
Dear …….., 
I am a student at Walden University pursuing my Doctor of Business 
Administration degree specializing in Technology Entrepreneurship. I am conducting a 
research study for my dissertation entitled “Strategies for Compliance with Government 
Regulations in a Pharmaceutical Company”. 
 The purpose of this qualitative single case study is to explore strategies that 
managers in pharmaceutical companies use to ensure compliance with regulatory 
requirements. Management approval for data collection will be sought, and your 
participation in this study is entirely voluntary, you can withdraw from participating at 
any point of the data collection process.  
Participants in this study are not likely to benefit personally or financially by 
participating, but participation has the potential for improved abilities of managers to 
ensure compliance in a regulated environment, which might lead to increased access, 
availability, and affordability of pharmaceutical products by individuals with limited 
access to good healthcare.  
The research will be conducted in by accordance with Walden University and 
HHS guidelines on ethical research. All participants and organizations will be kept 
confidential. Interested companies will be credited if they so desire in the final report. 
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Please review the consent form attached and if you accept this invitation to 
participate in the data collection phase of this study, please 
 Please do not hesitate to contact me if you have any question or concerns. 
Kind regards, 
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